101
|
Jiang Z, Diao P, Liang Y, Dai K, Li H, Wang H, Chen Y, Man L, Kuang Y. A Light Gradient Boosting Machine-Enabled Early Prediction of Cardiotoxicity for Breast Cancer Patients. Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.771] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
102
|
Jin F, Chen Y, Jiang Z, Li Y, Zhao C, Liu L, He Q, Li Y. The Correlation Study of Circadian Clock Gene BMAL1 Regulates the Biological Behavior of Human Nasopharyngeal Carcinoma Cell After Radiotherapy. Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.785] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
103
|
Jiang Z, Sun H, Yu J, Tian W, Song Y. Targeting CD47 for cancer immunotherapy. J Hematol Oncol 2021; 14:180. [PMID: 34717705 PMCID: PMC8557524 DOI: 10.1186/s13045-021-01197-w] [Citation(s) in RCA: 162] [Impact Index Per Article: 54.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2021] [Accepted: 10/19/2021] [Indexed: 02/04/2023] Open
Abstract
Much progress has been made in targeting CD47 for cancer immunotherapy in solid tumors (ST) and hematological malignancies. We summarized the CD47-related clinical research and analyzed the research trend both in the USA and in China. As of August 28, 2021, there are a total 23 related therapeutic agents with 46 clinical trials in the NCT registry platform. Among these trials, 29 are in ST, 14 in hematological malignancies and 3 in both solid tumor and hematological malignancy. The ST include gastric cancer, head and neck squamous cell carcinoma and leiomyosarcoma, while the hematological malignancies include non-Hodgkin's lymphoma, acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and chronic myeloid leukemia. Majority of the CD47-related clinical trials are at the early phases, such as 31 at phase I, 14 at phase II and 1 at phase III in the USA and 9, 6, 1, in China, respectively. The targets and spectrums of mechanism of action include 26 with mono-specific and 20 with bi-specific targets in the USA and 13 with mono-specific and 3 with bi-specific targets in China. The new generation CD47 antibodies have demonstrated promising results, and it is highly hopeful that some candidate agents will emerge and make into clinical application to meet the urgent needs of patients.
Collapse
|
104
|
Jiang Z, Chen H, Chen L, Huang Q, Zhang Q, Zhou J, Li Q, Wang D, Jiang M, Liu Y, Ma Y, Xiang L. Epidemiology and clinicopathology in genital dermatoses: a retrospective study of 3052 skin biopsy cases. J Eur Acad Dermatol Venereol 2021; 36:e240-e242. [PMID: 34704626 DOI: 10.1111/jdv.17774] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2021] [Accepted: 10/22/2021] [Indexed: 11/26/2022]
|
105
|
Fan Y, Liao L, Liu Y, Wu Z, Wang C, Jiang Z, Wang S, Liu Y. Risk factors affect accurate prognosis in ASXL1-mutated acute myeloid leukemia. Cancer Cell Int 2021; 21:526. [PMID: 34627254 PMCID: PMC8502294 DOI: 10.1186/s12935-021-02233-y] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2021] [Accepted: 09/28/2021] [Indexed: 12/18/2022] Open
Abstract
Background The epigenetic regulator additional sex combs-like 1 (ASXL1) is an adverse prognostic factor in acute myeloid leukemia (AML). However, the mutational spectrum and prognostic factors of ASXL1-mutated (ASXL1+) AML are largely unknown. We aim to evaluate the risk factors influencing the prognosis of ASXL1+ AML. Methods We performed next-generation sequencing (NGS) in 1047 cases of de novo AML and discovered 91 ASXL1+ AML (8.7%). The Log-Rank test and Kaplan-Meier were used to evaluate survival rate, and the Cox regression model was used to analyze multivariate analysis. Results In a total of 91 ASXL1+ AML, 86% had one or more co-mutations. The factors that had adverse impact on overall survival (OS) and event-free survival (EFS) are defined as high risk factors, including age ≥ 60 years, WBC count ≥ 50 × 109/L, FLT3-ITD mutations, RUNX1 mutations, and absence of AML1-ETO fusion gene. ASXL1 mutations without any risk factor were classified as single-hit ASXL1+ AML; ASXL1 mutations accompanied with one of the risk factors was referred to as double-hit ASXL1+ AML; ASXL1 mutations with two or more of the risk factors were designated as triple-hit ASXL1+ AML. The combination of these risk factors had a negative influence on the prognosis of ASXL1+ AML. The median OS was not attained in single-hit ASXL1+ AML, 29.53 months in double-hit ASXL1+ AML, and 6.67 months in triple-hit ASXL1+ AML (P = 0.003). The median EFS was not attained in single-hit ASXL1+ AML, 29.53 months in double-hit ASXL1+ AML, and 5.47 months in triple-hit ASXL1+ AML (P = 0.002). Allogenic hematopoietic stem cell transplantation (allo-HSCT) improved the prognosis of double/triple-hit ASXL1+ AML patients. Conclusions Our study provided new insights into the mutational spectrum and prognostic factors of ASXL1+ AML patients. Our primary data suggest that the risk factors in ASXL1+ AML contribute to the poor outcome of these patients. The management of ASXL1+ AML patients should be based on the risk factors and allo-HSCT is highly recommended for consolidation. Supplementary Information The online version contains supplementary material available at 10.1186/s12935-021-02233-y.
Collapse
|
106
|
Li M, Liu Y, Liu Y, Yang L, Xu Y, Wang W, Jiang Z, Liu Y, Wang S, Wang C. Downregulation of GNA15 Inhibits Cell Proliferation via P38 MAPK Pathway and Correlates with Prognosis of Adult Acute Myeloid Leukemia With Normal Karyotype. Front Oncol 2021; 11:724435. [PMID: 34552875 PMCID: PMC8451478 DOI: 10.3389/fonc.2021.724435] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2021] [Accepted: 08/17/2021] [Indexed: 11/13/2022] Open
Abstract
Background The prognosis of acute myeloid leukemia (AML) with a normal karyotype is highly heterogonous, and the current risk stratification is still insufficient to differentiate patients from high-risk to standard-risk. Changes in some genetic profiles may contribute to the poor prognosis of AML. Although the prognostic value of G protein subunit alpha 15 (GNA15) in AML has been reported based on the GEO (Gene Expression Omnibus) database, the prognostic significance of GNA15 has not been verified in clinical samples. The biological functions of GNA15 in AML development remain open to investigation. This study explored the clinical significance, biological effects and molecular mechanism of GNA15 in AML. Methods Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to detect the mRNA expression level of GNA15 in blasts of bone marrow specimens from 154 newly diagnosed adult AML patients and 26 healthy volunteers. AML cell lines, Kasumi-1 and SKNO-1, were used for lentiviral transfection. Cell Counting Kit-8 (CCK8) and colony formation assays were used to determine cell proliferation. Cell cycle and apoptosis were analyzed by flow cytometry. The relevant signaling pathways were evaluated by Western blot. The Log-Rank test and Kaplan-Meier were used to evaluate survival rate, and the Cox regression model was used to analyze multivariate analysis. Xenograft tumor mouse model was used for in vivo experiments. Results The expression of GNA15 in adult AML was significantly higher than that in healthy individuals. Subjects with high GNA15 expression showed lower overall survival and relapse-free survival in adult AML with normal karyotype. High GNA15 expression was independently correlated with a worse prognosis in multivariate analysis. Knockdown of GNA15 inhibited cell proliferation and cell cycle progression, and induced cell apoptosis in AML cells. GNA15-knockdown induced down-regulation of p-P38 MAPK and its downstream p-MAPKAPK2 and p-CREB. Rescue assays confirmed that P38 MAPK signaling pathway was involved in the inhibition of proliferation mediated by GNA15 knockdown. Conclusions In summary, GNA15 was highly expressed in adult AML, and high GNA15 expression was independently correlated with a worse prognosis in adult AML with normal karyotype. Knockdown of GNA15 inhibited the proliferation of AML regulated by the P38 MAPK signaling pathway. Therefore, GNA15 may serve as a potential prognostic marker and a therapeutic target for AML in the future.
Collapse
|
107
|
Zhao F, Wu Y, Zhou F, Xue D, Zhao S, Lu W, Liu X, Hu T, Qiu Y, Li R, Gu T, Xu Y, Xu F, Zhong G, Jiang Z, Zhao S, Tao H. Elucidation of Distinct Modular Assemblies of Smoothened Receptor by Bitopic Ligand Measurement. J Med Chem 2021; 64:13830-13840. [PMID: 34492176 DOI: 10.1021/acs.jmedchem.1c01220] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
Class F G protein-coupled receptors are characterized by a large extracellular domain (ECD) in addition to the common transmembrane domain (TMD) with seven α-helixes. For smoothened receptor (SMO), structural studies revealed dissected ECD and TMD, and their integrated assemblies. However, distinct assemblies were reported under different circumstances. Using an unbiased approach based on four series of cross-conjugated bitopic ligands, we explore the relationship between the active status and receptor assembly. Different activity dependency on the linker length for these bitopic ligands corroborates the various occurrences of SMO assembly. These results reveal a rigid "near" assembly for active SMO, which is in contrast to previous results. Conversely, inactive SMO adopts a free ECD, which would be remotely captured at "far" assembly by cholesterol. Altogether, we propose a mechanism of cholesterol flow-caused SMO activation involving an erection of ECD from far to near assembly.
Collapse
|
108
|
Zhang S, Li L, Cao W, Li Y, Jiang Z, Yu J, Wan D. Donor cell leukemia/myelodysplastic syndrome after allogeneic stem cell transplantation: a rare phenomenon with more challenges for hematologists. ACTA ACUST UNITED AC 2021; 26:648-651. [PMID: 34474660 DOI: 10.1080/16078454.2021.1966224] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
Donor cell leukemia (DCL) or Donor cell myelodysplastic syndrome (DC-MDS) is a rare type of leukemia or MDS and originates from the donor cells. It has very low frequency, but it seems to be steadily increasing as the physiopathology and mechanisms remain largely unknown. Here we report one case of acute lymphocytic leukemia (ALL) and one case of MDS of donor origin after allogeneic hematopoietic stem cell transplantation (HSCT). We also collated and reviewed literatures regarding DCL, and discuss the morbidity of DCL, the methods used to confirm donor origin and the etiology and pathogenesis of DCL. A new proposed theory will help us to better understand the mechanism for the oncogenesis of DCL.
Collapse
|
109
|
Tolaney S, Barroso-Sousa R, Jiang Z, Park Y, Rimawi M, Saura Manich C, Schneeweiss A, Toi M, Yu T, Shetty J, Herbolsheimer P, Loibl S. 328TiP Phase III study of trastuzumab deruxtecan (T-DXd) with or without pertuzumab vs a taxane, trastuzumab and pertuzumab in first-line (1L), human epidermal growth factor receptor 2–positive (HER2+) metastatic breast cancer (mBC): DESTINY-Breast09. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.611] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
110
|
Xiao Y, Wang H, Tang Y, Yan J, Cao L, Chen Z, Shao Z, Mei Z, Jiang Z. Increased risk of diabetes in cancer survivors: a pooled analysis of 13 population-based cohort studies. ESMO Open 2021; 6:100218. [PMID: 34303930 PMCID: PMC8327494 DOI: 10.1016/j.esmoop.2021.100218] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2021] [Revised: 06/25/2021] [Accepted: 06/28/2021] [Indexed: 01/04/2023] Open
Abstract
BACKGROUND Diabetes is considered as an established risk factor for cancer development. However, the link between diabetes among cancer survivors remains inconclusive. The hypothesis of this study was to assess the hazard ratio (HR) of incidence of diabetes in cancer survivors compared with the HR in the general population. PATIENTS AND METHODS A comprehensive literature search was performed in PubMed, Embase, and the Cochrane Library from database inception to 15 December 2020 for population-based cohort studies. Summary effect estimates were combined using random-effects models. We also performed subgroup analyses to test sources of heterogeneity and the stability of the results stratified by various study and participant characteristics. RESULTS Thirteen population-based cohort studies involving 1 686 595 participants were analyzed. The HR for the development of diabetes in cancer survivors was 1.39 [95% confidence interval (CI) 1.29-1.50; I2 = 82.3%; P < 0.001] compared with that in noncancer controls, among which survivors of hematological, gynecologic, breast, colorectal and urinary tract cancer (all P < 0.05) showed consistent significant results, whereas no significant increased risk was observed for other cancer types. The effects were more prominent in populations of shorter cancer survival duration (<1 year) (HR 2.09, 95% CI 1.32-3.32; P = 0.009). Moreover, cancer survivors with a longer follow-up period (>10 years) had a relatively higher risk of diabetes (HR 1.54, 95% CI 1.34-1.77) than those with a shorter follow-up period. CONCLUSIONS In this large pooled analysis of population-based cohorts, evidence supports the hypothesis that the risk of developing diabetes is increased in cancer survivors compared with the general population. We should interpret the results with caution for considerable interstudy heterogeneity. However, health policy makers should take this as a challenge for the early prevention and effective intervention of diabetes.
Collapse
|
111
|
Cai Z, Liu C, Shen C, Jiang Z, Mu M, Zhang B. P-227 Comparative safety and tolerability of approved PARP inhibitors in cancer: A systematic review and network meta-analysis. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.05.281] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
112
|
Li X, Cao W, Zhang S, Li L, Li Y, Jiang Z, Wan D, Yu J. Philadelphia chromosome-positive B-lymphoblastic lymphoma successfully treated with chemotherapy regimen containing imatinib: A rare case report and literature review. Medicine (Baltimore) 2021; 100:e26323. [PMID: 34115047 PMCID: PMC8202563 DOI: 10.1097/md.0000000000026323] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/29/2021] [Accepted: 05/25/2021] [Indexed: 01/04/2023] Open
Abstract
RATIONALE B-lymphoblastic lymphoma (B-LBL) with BCR/ABL mutation (Ph+ B-LBL) is a rare type of cancer in both childhood and adults. Its clinical manifestations are similar to those of other types lymphoma. However, the targeted therapy can substantially improve the outcome of Ph+ B-LBL. PATIENT CONCERNS A 19-year-old male with blood type O, Rh+ was admitted into our hospital on August 14, 2018, due to a recurrent fever and hypocytosis for 6 months. DIAGNOSES Routine blood exam showed pancytopenia. Bone marrow sample flow cytometry (FCM) exam showed abnormal cells were 2.27% of the nucleated cells, and was classified as the abnormal early B-lineage lymphoblastic cells. FISH testing showed the BCR/ABL positive cells were 13.6%. Karyotype analysis showed the 46, XY, t(9;22)(q34;q11). Molecular analysis of BCR/ABL mutation on ABL kinase showed that BCR/ABL T315I mutation. Patient was diagnosed with B-LBL with BCR/ABL mutation (Ph+ B-LBL). INTERVENTIONS The patient was given chemotherapy with VDPI regimen (Vinorelbine, daunorubicin, prednisone, imatinib). OUTCOMES The patient achieved complete remission after 2 courses' treatment, followed by one course of clarithromycin regimen and another two courses of VDPI regimen. Patient remains in complete remission as of March 10, 2021. LESSONS In B-LBL, a BCR/ABL mutation can happen in some of these patients. It is important to guide the pathologist to perform appropriate gene mutation detection, in addition to routine Immunohistochemistry test, to ensure an accurate diagnosis and use the targeted agent for treatment. According to the literature and our results, it seems that intensive chemotherapy plus TKI regimen is effective in inducing complete remission, and allo-SCT should be used as a long-term strategy.
Collapse
|
113
|
Chen C, Yang S, Jiang Z, Wan W, Zou H, Liang M. POS0884 THE ENHANCED LIVER FIBROSIS (ELF) SCORE AS A BIOMARKER OF SKIN FIBROSIS IN SYSTEMIC SCLEROSIS. Ann Rheum Dis 2021. [DOI: 10.1136/annrheumdis-2021-eular.3648] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:Serum fibrotic markers for systemic sclerosis (SSc) remain limited. The Enhanced Liver Fibrosis (ELF) score, originally derived and validated in patients with chronic liver disease, is an algorithm combining 3 serum markers, known as procollagen type III amino terminal propeptide (PIIINP), tissue inhibitor of metalloproteinases 1 (TIMP-1), and hyaluronic acid (HA). The combined score was proved to be superior to the single components in reflecting the severity of liver fibrosis. However, the performance of ELF score and its components has not been fully validated in SSc.Objectives:To investigate PIIINP, TIMP-1, HA, and the combined algorithm ELF score as fibrotic markers for SSc skin involvement.Methods:Eighty SSc patients (44 dcSSc and 36 lcSSc), fulfilling the 2013 ACR/EULAR criteria with the absence of chronic liver diseases, were enrolled. Eighty age- and sex- matched healthy controls were also included. Serum PIIINP and HA levels were quantified by chemiluminescence immunoassay. Serum TIMP-1 levels were determined by enzyme-linked immunosorbent assay. The ELF score was calculated using the formula ELF score= 2.494 + 0.846*ln(HA) + 0.735*ln(PIIINP) + 0.391*ln(TIMP-1). Results were correlated with clinical profiles including modified Rodnan skin score (mRSS) and interstitial lung disease (ILD).Results:Compared with healthy controls, patients with SSc showed significantly elevated serum PIIINP (11.2±4.8 vs. 5.73±1.4μg/L, p<0.001), TIMP-I (123.7±78.6 vs. 67.8±26.5 ng/ml, p<0.001), and ELF score (10.5±0.9 vs. 9.7±0.4, P<0.001). Even higher levels of PIIINP, TIMP-1, and ELF score were observed in dcSSc patients, compared with lcSSc patients (p<0.001, p=0.024, p=0.003, respectively). No significant difference was found in the levels of serum HA between patients and controls. Strong correlations were observed between mRSS and ELF score (r=0.54, p<0.001), and between mRSS and PIIINP(r=0.62, p<0.001), whereas only weak correlations could be observed between mRSS and TIMP-1 (r=0.28, p=0.02), and between mRSS and HA (r=0.26, p=0.03). When stratified by ELF score, using cutoffs proposed for liver fibrosis and cirrhosis, SSc patients with ELF<9.8 showed the lowest mRSS on average, while patients with ELF>11.3 showed the highest (p<0.001). When stratified by serum PIIINP levels, using the 25th and 75th percentiles, SSc patients with serum PIIIINP levels<7.8μg/L showed the lowest mRSS on average, while patients with PIIINP>14.0μg/L showed the highest (p<0.001). Neither the ELF score nor its components showed significant difference between patients with and without ILD.Conclusion:The ELF score could be used for reflecting the severity of overall skin involvement in SSc, and serum PIIINP also increased in parallel with the increase of mRSS. Longitudinal prospective studies exploring ELF score or serum PIIINP as fibrotic markers and outcome measures of SSc are warranted.References:[1]Lichtinghagen R, Pietsch D, Bantel H, et al. The Enhanced Liver Fibrosis (ELF) score: Normal values, influence factors and proposed cut-off values. Journal of Hepatology. 2013; 59: 236-42.[2]Abignano G, Blagojevic J, Bissell LA, et al. European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis. Rheumatology. 2019; 58: 254-59.Figure 1.Correlations of mRSS with ELF score (A) and serum PIIINP (B) and distribution of mRSS among different ELF (C) and PIIINP (D) ranges.Acknowledgements:The authors have no acknowledgements to declare.Disclosure of Interests:None declared
Collapse
|
114
|
Chen C, Yang S, Jiang Z, Wan W, Zou H, Liang M. POS0869 PREDICTIVE VALUE OF ANTI-INTERFERON-INDUCIBLE PROTEIN 16 ANTIBODIES FOR DIGITAL ULCERS OF SYSTEMIC SCLEROSIS. Ann Rheum Dis 2021. [DOI: 10.1136/annrheumdis-2021-eular.3058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:Interferon-inducible protein 16 (IFI-16) is constitutively expressed in vascular endothelial cells and can inhibit the proliferation of human endothelial cells and the formation of capillary-like structures in vitro. Anti-IFI-16 antibodies were reported in 21%-29% of patients with systemic sclerosis (SSc) and were associated with digital vascular events in a few retrospective studies.Objectives:To evaluate the presence and the clinical implication of anti-IFI-16 antibodies in Chinese SSc cohort, focusing on the associations with vasculopathy indexes, and to investigate the predictive value of anti-IFI-16 antibodies for the development of digital ulcers (DUs) in SSc prospectively.Methods:Patients with SSc presenting to our center between July 2018 and September 2018 were prospectively enrolled. Serum from 42 SSc patients and 42 age- and sex-matched healthy controls were analyzed for anti-IFI-16 antibodies by enzyme-linked immunosorbent assay (ELISA), and was considered positive if the optical density (OD) value was above the mean OD of controls plus two standard deviations. Tissue immunofluorescence was used to evaluate the expression of IFI16 in skin biopsy samples obtained from SSc patients and normal controls. At baseline, nailfold video-capillaroscopy was performed to assess nailfold capillary density of SSc patients. Power Doppler ultrasound was used to grade finger pulp blood flow (0-no observed flow; 1-decreased flow; 2-normal flow), and to measure ulnar and radial artery blood flow and resistive index (RI). All patients were followed up for 6 months to see whether they experienced new onset or recurrent DUs. The association of anti-IFI-16 antibodies with DUs was analyzed using logistic regression.Results:Of the 42 SSc patients, 8 (19.0%) were positive for anti-IFI-16 antibodies. Immunofluorescence of skin biopsy samples from SSc patients exhibited enhanced staining of IFI-16 in the dermis, and colocalization with endothelial marker CD31. SSc patients who were positive for anti-IFI-16 antibodies showed higher ulnar artery RI at baseline (0.95±0.09 vs. 0.86±0.09, p=0.015), while no significant differences were found for other vascular parameters, nor for clinical or demographic profiles. Within 6-month follow-up, 14 (33.3%) patients experienced new-onset or recurrent DUs. Univariate logistic regression revealed the presence of DUs at enrollment (p=0.009), anti-IFI-16 antibody (p=0.012), finger pulp blood flow (p=0.027), and ulnar artery RI (p=0.008) could be the predictors for the development of DUs. Multivariate analysis further identified DUs at enrollment (odds ratio [OR]: 10.85; 95% confidence interval [CI]: 1.61-73.18; p=0.014) and anti-IFI-16 antibody (OR: 15.00; 95% CI: 1.13-199.18; p=0.040) as independent risk factors. Among patients without DUs at enrollment, new-onset ulcers occurred in 80% (4/5) and 4.5% (1/22) of those with and without anti-IFI-16 antibody, respectively (p=0.001).Conclusion:Anti-IFI-16 antibody is associated with vasculopathy in SSc and could be used as a novel biomarker for indicating the development of DUs.References:[1]McMahan ZH, Shah AA, Vaidya D, et al. Anti-interferon-inducible protein 16 antibodies associate with digital gangrene in patients with Scleroderma. Arthritis Rheumatol. 2016; 68(5): 1262-71.[2]McMahan ZH, Cottrell TR, Wigley FM, et al. Autoantigens targeted in scleroderma patients with vascular disease are enriched in endothelial lineage cells. Arthritis Rheumatol. 2016; 68(10): 2540–49.Figure 1.Multivariate logistic analysis for new or recurrent digital ulcers.Acknowledgements:The authors would like to thank Doctor Yi Cheng for performing Power Doppler ultrasound assessment.Disclosure of Interests:None declared
Collapse
|
115
|
Zeng X, Liu J, Liu X, Wu L, Liu Y, Liao X, Liu H, Hu J, Lu X, Chen L, Xu J, Jiang Z, Lu F, Wu H, Sun L, Wang M, Yu X, Wang Q. AB0197 EFFICACY AND SAFETY OF HLX01 COMBINED WITH METHOTREXATE IN CHINESE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS WHO HAD INADEQUATE RESPONSES TO METHOTREXATE: RESULTS OF A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY. Ann Rheum Dis 2021. [DOI: 10.1136/annrheumdis-2021-eular.282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:Rituximab is an effective therapy for rheumatoid arthritis (RA) patients with inadequate responses to methotrexate (MTX)1, 2. However, it has not been registered or approved in China for the treatment of RA by far. HLX01, an approved rituximab biosimilar (demonstrated in Chinese patients with diffuse large B-cell lymphoma)3, is thus evaluated in this study for the benefits of Chinese RA patients.Objectives:This study aimed to evaluate the efficacy and safety of HLX01 plus MTX versus placebo plus MTX in Chinese patients with active RA who had inadequate responses to MTX.Methods:This was a randomised, double-blind, placebo-controlled phase 3 study conducted in China (NCT03522415). Eligible patients were randomised 2:1 to receive intravenous infusion of 2×1000 mg HLX01 or placebo on day 1 and day 15. Patients with inadequate responses at week 16 and 20 were allowed to receive rescue treatments. Patients were retreated with or switched to receive (if initially assigned to placebo) 2×1000 mg rituximab at the first day of week 24 and 26. The primary endpoint of this study was the American College of Rheumatology criteria (ACR) 20 response at week 24. Secondary efficacy endpoints were evaluated at week 12, 24, 36 and 48. The safety, pharmacokinetics, pharmacodynamics and immunogenicity of HLX01 were observed and analyzed throughout the study.Results:Between May 28, 2018 and Sep 11, 2020, a total of 275 patients (ITT set) were randomised and 263 patients without major protocol deviations were included in per-protocol set (PPS). At week 24, HLX01 showed statistically superior efficacy (p <0.001) to placebo (ACR20: 60.7% vs 35.9% in ITT set, 60.3% vs 37.1% in PPS). Secondary efficacy endpoints were also significantly improved in HLX01 group compared with placebo (Table 1). The overall incidence of serious treatment emergent adverse events (TEAEs), adverse drug reactions (ADRs), and TEAEs leading to drug discontinuation were similar among treatment groups, with the most common TEAE been upper respiratory tract infection before (18.1% vs 18.5%) or after (13.0% vs 12.3%) week 24. Serum concentrations, immunogenicity and pharmacodynamics were similar between HLX01 and placebo groups.Table 1.Results of secondary efficacy endpoints at week 12, 24, 36 and 48 in ITT set.DurationSecondary efficacy endpointsACR20 (%)ACR50 (%)ACR70 (%)DAS28-CRP(mean)HAQ-DI(mean)HLX01PlaceboHLX01PlaceboHLX01PlaceboHLX01PlaceboHLX01PlaceboBaseline5.495.431.401.45Week 1248.132.621.910.94.45.43.894.471.021.22Week 2460.735.936.618.515.312.03.394.370.871.22Week 3660.148.946.431.532.217.42.883.510.710.97Week 4873.862.055.240.239.927.22.823.510.721.03Conclusion:Comparing with placebo plus MTX, HLX01 plus MTX showed significantly improved clinical outcomes and comparable safety profiles in Chinese patients with moderately to severely active RA who had inadequate responses to MTX, demonstrating HLX01 in combination with MTX as a well-tolerated, safe and efficient treatment option.References:[1]Emery P, Deodhar A, Rigby WF, et al. Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab’s Efficacy in MTX iNadequate rEsponders (SERENE)). Ann Rheum Dis. Sep 2010;69(9):1629-35. doi:10.1136/ard.2009.119933.[2]Rubbert-Roth A, Tak PP, Zerbini C, et al. Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR). Rheumatology (Oxford). Sep 2010;49(9):1683-93. doi:10.1093/rheumatology/keq116.[3]Shi Y, Song Y, Qin Y, et al. A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma. J Hematol Oncol. Apr 16 2020;13(1):38. doi:10.1186/s13045-020-00871-9.Acknowledgements:The authors would like to thank participants in this study and their families. They would also like to acknowledge other investigators and staff at all clinical sites and the members of the Independent Data Monitoring Committee.Disclosure of Interests:None declared
Collapse
|
116
|
Shen B, Hoshmand-Kochi M, Abbasi A, Glass S, Jiang Z, Singer AJ, Thode HC, Li H, Hou W, Duong TQ. Initial chest radiograph scores inform COVID-19 status, intensive care unit admission and need for mechanical ventilation. Clin Radiol 2021; 76:473.e1-473.e7. [PMID: 33706997 PMCID: PMC7891126 DOI: 10.1016/j.crad.2021.02.005] [Citation(s) in RCA: 20] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2020] [Accepted: 02/08/2021] [Indexed: 12/15/2022]
Abstract
AIM To evaluate whether portable chest radiography (CXR) scores are associated with coronavirus disease 2019 (COVID-19) status and various clinical outcomes. MATERIALS AND METHODS This retrospective study included 500 initial CXR from COVID-19-suspected patients. Each CXR was scored based on geographic extent and degree of opacity as indicators of disease severity. COVID-19 status and clinical outcomes including intensive care unit (ICU) admission, mechanical ventilation, mortality, length of hospitalisation, and duration on ventilator were collected. Multivariable logistic regression analysis was performed to evaluate the relationship between CXR scores and COVID-19 status, CXR scores and clinical outcomes, adjusted for code status, age, gender and co-morbidities. RESULTS The interclass correlation coefficients amongst raters were 0.94 and 0.90 for the extent score and opacity score, respectively. CXR scores were significantly (p < 0.01) associated with COVID-19 positivity (odd ratio [OR] = 1.49; 95% confidence interval [CI]: 1.27 - 1.75 for extent score and OR = 1.75; 95% CI: 1.42 - 2.15 for opacity score), ICU admission (OR = 1.19; 95% CI: 1.09 - 1.31 for extent score and OR = 1.26; 95% CI: 1.10 - 1.44 for opacity score), and invasive mechanical ventilation (OR = 1.22; 95% CI: 1.11 - 1.35 for geographic score and OR = 1.21; 95% CI: 1.05 - 1.38 for opacity score). CXR scores were not significantly different between survivors and non-survivors after adjusting for code status (p>0.05). CXR scores were not associated with length of hospitalisation or duration on ventilation (p>0.05). CONCLUSIONS Initial CXR scores have prognostic value and are associated with COVID-19 positivity, ICU admission, and mechanical ventilation.
Collapse
|
117
|
Chen Q, Jiang Z, Zhang J, Cao L, Chen Z. Arecoline hydrobromide enhances jejunum smooth muscle contractility via voltage-dependent potassium channels in W/Wv mice. Physiol Res 2021; 70:437-446. [PMID: 33982580 DOI: 10.33549/physiolres.934557] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
Gastrointestinal motility was disturbed in W/Wv, which were lacking of interstitial cells of Cajal (ICC). In this study, we have investigated the role of arecoline hydrobromide (AH) on smooth muscle motility in the jejunum of W/Wv and wild-type (WT) mice. The jejunum tension was recorded by an isometric force transducer. Intracellular recording was used to identify whether AH affects slow wave and resting membrane potential (RMP) in vitro. The whole-cell patch clamp technique was used to explore the effects of AH on voltage-dependent potassium channels for jejunum smooth muscle cells. AH enhanced W/Wv and WT jejunum contractility in a dose-dependent manner. Atropine and nicardipine completely blocked the excitatory effect of AH in both W/Wv and WT. TEA did not reduce the effect of AH in WT, but was sufficient to block the excitatory effect of AH in W/Wv. AH significantly depolarized the RMP of jejunum cells in W/Wv and WT. After pretreatment with TEA, the RMP of jejunum cells indicated depolarization in W/Wv and WT, but subsequently perfused AH had no additional effect on RMP. AH inhibited the voltage-dependent K+ currents of acutely isolated mouse jejunum smooth muscle cells. Our study demonstrate that AH enhances the contraction activity of jejunum smooth muscle, an effect which is mediated by voltage-dependent potassium channels that acts to enhance the excitability of jejunum smooth muscle cells in mice.
Collapse
|
118
|
Li Y, Wan D, Guo R, Wang F, Han L, Zhang D, Xing H, Cao W, Liu Y, Xie X, Yu J, Jiang Z. Decreased bone marrow regulatory innate lymphoid cells show a distinctive miRNA profiling in aplastic anemia. ACTA ACUST UNITED AC 2021; 26:37-42. [PMID: 33375909 DOI: 10.1080/16078454.2020.1866304] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
OBJECTIVES A new regulatory subpopulation of innate lymphoid cells (ILCs), regulatory innate lymphoid cells (ILCregs), has been identified with both innate lymphoid cells and regulatory cells characteristics. The purpose of this study is to explore ILCregs and its associated miRNAs in patients with aplastic anemia (AA) by evaluating ILCregs frequency, associated miRNA quantification, and their significance. METHODS Using 4 color combinations of surface and intracellular antibody staining, the CD45+Lin-CD127+IL-10+ ILCregs from 30 healthy donors and 30 patients newly diagnosed with AA were measured by flow cytometry. Bone marrow cells were studied by next-generation sequence miRNAs quantification. RESULTS Our results showed that the frequency of ILCregs in bone marrow cells from healthy donors (HD) and AA patients were 0.703 ± 0.941 and 0.171 ± 0.233%, respectively. The frequencies of ILCregs in AA patients were significantly lower than that in HD (p <0.05). miRNA detection results showed different expression patterns in the AA patient group comparing with HD. Comparing with HD, there were 52 miRNAs up-regulated and 130 miRNAs down-regulated from AA patients. Analysis of miRNAs from ILCregs associated genes demonstrated different miRNAs expression patterns between HD and AA patient. CONCLUSION The present study demonstrated the deficiency of ILCregs and differential expression pattern of ILCregs gene-related miRNA in patients with AA. Further studies need to be done to explore the clinical significance of ILCregs and related miRNAs in patients with AA with large samples size and clinical follow-up.
Collapse
|
119
|
Aad G, Abbott B, Abbott DC, Abed Abud A, Abeling K, Abhayasinghe DK, Abidi SH, AbouZeid OS, Abraham NL, Abramowicz H, Abreu H, Abulaiti Y, Acharya BS, Achkar B, Adachi S, Adam L, Adam Bourdarios C, Adamczyk L, Adamek L, Adelman J, Adersberger M, Adiguzel A, Adorni S, Adye T, Affolder AA, Afik Y, Agapopoulou C, Agaras MN, Aggarwal A, Agheorghiesei C, Aguilar-Saavedra JA, Ahmadov F, Ahmed WS, Ai X, Aielli G, Akatsuka S, Åkesson TPA, Akilli E, Akimov AV, Al Khoury K, Alberghi GL, Albert J, Alconada Verzini MJ, Alderweireldt S, Aleksa M, Aleksandrov IN, Alexa C, Alexopoulos T, Alfonsi A, Alfonsi F, Alhroob M, Ali B, Aliev M, Alimonti G, Allaire C, Allbrooke BMM, Allen BW, Allport PP, Aloisio A, Alonso F, Alpigiani C, Alshehri AA, Alunno Camelia E, Alvarez Estevez M, Alviggi MG, Amaral Coutinho Y, Ambler A, Ambroz L, Amelung C, Amidei D, Amor Dos Santos SP, Amoroso S, Amrouche CS, An F, Anastopoulos C, Andari N, Andeen T, Anders CF, Anders JK, Andrean SY, Andreazza A, Andrei V, Anelli CR, Angelidakis S, Angerami A, Anisenkov AV, Annovi A, Antel C, Anthony MT, Antipov E, Antonelli M, Antrim DJA, Anulli F, Aoki M, Aparisi Pozo JA, Aparo MA, Aperio Bella L, Araque JP, Araujo Ferraz V, Araujo Pereira R, Arcangeletti C, Arce ATH, Arduh FA, Arguin JF, Argyropoulos S, Arling JH, Armbruster AJ, Armstrong A, Arnaez O, Arnold H, Arrubarrena Tame ZP, Artoni G, Artz S, Asai S, Asawatavonvanich T, Asbah N, Asimakopoulou EM, Asquith L, Assahsah J, Assamagan K, Astalos R, Atkin RJ, Atkinson M, Atlay NB, Atmani H, Augsten K, Avolio G, Ayoub MK, Azuelos G, Bachacou H, Bachas K, Backes M, Backman F, Bagnaia P, Bahmani M, Bahrasemani H, Bailey AJ, Bailey VR, Baines JT, Bakalis C, Baker OK, Bakker PJ, Bakshi Gupta D, Balaji S, Baldin EM, Balek P, Balli F, Balunas WK, Balz J, Banas E, Bandieramonte M, Bandyopadhyay A, Banerjee S, Barak L, Barbe WM, Barberio EL, Barberis D, Barbero M, Barbour G, Barillari T, Barisits MS, Barkeloo J, Barklow T, Barnea R, Barnett BM, Barnett RM, Barnovska-Blenessy Z, Baroncelli A, Barone G, Barr AJ, Barranco Navarro L, Barreiro F, Barreiro Guimarães da Costa J, Barsov S, Bartels F, Bartoldus R, Bartolini G, Barton AE, Bartos P, Basalaev A, Basan A, Bassalat A, Basso MJ, Bates RL, Batlamous S, Batley JR, Batool B, Battaglia M, Bauce M, Bauer F, Bauer KT, Bawa HS, Beacham JB, Beau T, Beauchemin PH, Becherer F, Bechtle P, Beck HC, Beck HP, Becker K, Becot C, Beddall A, Beddall AJ, Bednyakov VA, Bedognetti M, Bee CP, Beermann TA, Begalli M, Begel M, Behera A, Behr JK, Beisiegel F, Bell AS, Bella G, Bellagamba L, Bellerive A, Bellos P, Beloborodov K, Belotskiy K, Belyaev NL, Benchekroun D, Benekos N, Benhammou Y, Benjamin DP, Benoit M, Bensinger JR, Bentvelsen S, Beresford L, Beretta M, Berge D, Bergeaas Kuutmann E, Berger N, Bergmann B, Bergsten LJ, Beringer J, Berlendis S, Bernardi G, Bernius C, Bernlochner FU, Berry T, Berta P, Bertella C, Bertram IA, Bessidskaia Bylund O, Besson N, Bethani A, Bethke S, Betti A, Bevan AJ, Beyer J, Bhattacharya DS, Bhattarai P, Bi R, Bianchi RM, Biebel O, Biedermann D, Bielski R, Bierwagen K, Biesuz NV, Biglietti M, Billoud TRV, Bindi M, Bingul A, Bini C, Biondi S, Birman M, Bisanz T, Biswal JP, Biswas D, Bitadze A, Bittrich C, Bjørke K, Blazek T, Bloch I, Blocker C, Blue A, Blumenschein U, Bobbink GJ, Bobrovnikov VS, Bocchetta SS, Bocci A, Bogavac D, Bogdanchikov AG, Bohm C, Boisvert V, Bokan P, Bold T, Bolz AE, Bomben M, Bona M, Bonilla JS, Boonekamp M, Booth CD, Borecka-Bielska HM, Borgna LS, Borisov A, Borissov G, Bortfeldt J, Bortoletto D, Boscherini D, Bosman M, Bossio Sola JD, Bouaouda K, Boudreau J, Bouhova-Thacker EV, Boumediene D, Boutle SK, Boveia A, Boyd J, Boye D, Boyko IR, Bozson AJ, Bracinik J, Brahimi N, Brandt G, Brandt O, Braren F, Brau B, Brau JE, Breaden Madden WD, Brendlinger K, Brenner L, Brenner R, Bressler S, Brickwedde B, Briglin DL, Britton D, Britzger D, Brock I, Brock R, Brooijmans G, Brooks WK, Brost E, Broughton JH, Bruckman de Renstrom PA, Bruncko D, Bruni A, Bruni G, Bruni LS, Bruno S, Bruschi M, Bruscino N, Bryngemark L, Buanes T, Buat Q, Buchholz P, Buckley AG, Budagov IA, Bugge MK, Bührer F, Bulekov O, Burch TJ, Burdin S, Burgard CD, Burger AM, Burghgrave B, Burr JTP, Burton CD, Burzynski JC, Büscher V, Buschmann E, Bussey PJ, Butler JM, Buttar CM, Butterworth JM, Butti P, Buttinger W, Buxo Vazquez CJ, Buzatu A, Buzykaev AR, Cabras G, Cabrera Urbán S, Caforio D, Cai H, Cairo VMM, Cakir O, Calace N, Calafiura P, Calderini G, Calfayan P, Callea G, Caloba LP, Caltabiano A, Calvente Lopez S, Calvet D, Calvet S, Calvet TP, Calvetti M, Camacho Toro R, Camarda S, Camarero Munoz D, Camarri P, Cameron D, Camincher C, Campana S, Campanelli M, Camplani A, Campoverde A, Canale V, Canesse A, Cano Bret M, Cantero J, Cao T, Cao Y, Capeans Garrido MDM, Capua M, Cardarelli R, Cardillo F, Carducci G, Carli I, Carli T, Carlino G, Carlson BT, Carlson EM, Carminati L, Carney RMD, Caron S, Carquin E, Carrá S, Carter JWS, Casado MP, Casha AF, Castillo FL, Castillo Garcia L, Castillo Gimenez V, Castro NF, Catinaccio A, Catmore JR, Cattai A, Cavaliere V, Cavallaro E, Cavalli-Sforza M, Cavasinni V, Celebi E, Cerda Alberich L, Cerny K, Cerqueira AS, Cerri A, Cerrito L, Cerutti F, Cervelli A, Cetin SA, Chadi Z, Chakraborty D, Chan J, Chan WS, Chan WY, Chapman JD, Chargeishvili B, Charlton DG, Charman TP, Chau CC, Che S, Chekanov S, Chekulaev SV, Chelkov GA, Chen B, Chen C, Chen CH, Chen H, Chen J, Chen J, Chen J, Chen S, Chen SJ, Chen X, Chen YH, Cheng HC, Cheng HJ, Cheplakov A, Cheremushkina E, Cherkaoui El Moursli R, Cheu E, Cheung K, Chevalérias TJA, Chevalier L, Chiarella V, Chiarelli G, Chiodini G, Chisholm AS, Chitan A, Chiu I, Chiu YH, Chizhov MV, Choi K, Chomont AR, Chouridou S, Chow YS, Chu MC, Chu X, Chudoba J, Chwastowski JJ, Chytka L, Cieri D, Ciesla KM, Cinca D, Cindro V, Cioară IA, Ciocio A, Cirotto F, Citron ZH, Citterio M, Ciubotaru DA, Ciungu BM, Clark A, Clark MR, Clark PJ, Clement C, Coadou Y, Cobal M, Coccaro A, Cochran J, Coelho Lopes De Sa R, Cohen H, Coimbra AEC, Cole B, Colijn AP, Collot J, Conde Muiño P, Connell SH, Connelly IA, Constantinescu S, Conventi F, Cooper-Sarkar AM, Cormier F, Cormier KJR, Corpe LD, Corradi M, Corrigan EE, Corriveau F, Costa MJ, Costanza F, Costanzo D, Cowan G, Cowley JW, Crane J, Cranmer K, Crawley SJ, Creager RA, Crépé-Renaudin S, Crescioli F, Cristinziani M, Croft V, Crosetti G, Cueto A, Cuhadar Donszelmann T, Cukierman AR, Cunningham WR, Czekierda S, Czodrowski P, Czurylo MM, Da Cunha Sargedas De Sousa MJ, Da Fonseca Pinto JV, Da Via C, Dabrowski W, Dachs F, Dado T, Dahbi S, Dai T, Dallapiccola C, Dam M, D'amen G, D'Amico V, Damp J, Dandoy JR, Daneri MF, Dann NS, Danninger M, Dao V, Darbo G, Dartsi O, Dattagupta A, Daubney T, D'Auria S, David C, Davidek T, Davis DR, Dawson I, De K, De Asmundis R, De Beurs M, De Castro S, De Cecco S, De Groot N, de Jong P, De la Torre H, De Maria A, De Pedis D, De Salvo A, De Sanctis U, De Santis M, De Santo A, De Vasconcelos Corga K, De Vivie De Regie JB, Debenedetti C, Dedovich DV, Deiana AM, Del Peso J, Delabat Diaz Y, Delgove D, Deliot F, Delitzsch CM, Della Pietra M, Della Volpe D, Dell'Acqua A, Dell'Asta L, Delmastro M, Delporte C, Delsart PA, DeMarco DA, Demers S, Demichev M, Demontigny G, Denisov SP, D'Eramo L, Derendarz D, Derkaoui JE, Derue F, Dervan P, Desch K, Deterre C, Dette K, Deutsch C, Devesa MR, Deviveiros PO, Di Bello FA, Di Ciaccio A, Di Ciaccio L, Di Clemente WK, Di Donato C, Di Girolamo A, Di Gregorio G, Di Micco B, Di Nardo R, Di Petrillo KF, Di Sipio R, Diaconu C, Dias FA, Dias Do Vale T, Diaz MA, Dickinson J, Diehl EB, Dietrich J, Díez Cornell S, Dimitrievska A, Ding W, Dingfelder J, Dittus F, Djama F, Djobava T, Djuvsland JI, Do Vale MAB, Dobre M, Dodsworth D, Doglioni C, Dolejsi J, Dolezal Z, Donadelli M, Dong B, Donini J, D'onofrio A, D'Onofrio M, Dopke J, Doria A, Dova MT, Doyle AT, Drechsler E, Dreyer E, Dreyer T, Drobac AS, Du D, Duan Y, Dubinin F, Dubovsky M, Dubreuil A, Duchovni E, Duckeck G, Ducourthial A, Ducu OA, Duda D, Dudarev A, Dudder AC, Duffield EM, Duflot L, Dührssen M, Dülsen C, Dumancic M, Dumitriu AE, Duncan AK, Dunford M, Duperrin A, Duran Yildiz H, Düren M, Durglishvili A, Duschinger D, Dutta B, Duvnjak D, Dyckes GI, Dyndal M, Dysch S, Dziedzic BS, Ecker KM, Eggleston MG, Eifert T, Eigen G, Einsweiler K, Ekelof T, El Jarrari H, El Kosseifi R, Ellajosyula V, Ellert M, Ellinghaus F, Elliot AA, Ellis N, Elmsheuser J, Elsing M, Emeliyanov D, Emerman A, Enari Y, Epland MB, Erdmann J, Ereditato A, Erland PA, Errenst M, Escalier M, Escobar C, Estrada Pastor O, Etzion E, Evans H, Evans MO, Ezhilov A, Fabbri F, Fabbri L, Fabiani V, Facini G, Faisca Rodrigues Pereira RM, Fakhrutdinov RM, Falciano S, Falke PJ, Falke S, Faltova J, Fang Y, Fang Y, Fanourakis G, Fanti M, Faraj M, Farbin A, Farilla A, Farina EM, Farooque T, Farrington SM, Farthouat P, Fassi F, Fassnacht P, Fassouliotis D, Faucci Giannelli M, Fawcett WJ, Fayard L, Fedin OL, Fedorko W, Fehr A, Feickert M, Feligioni L, Fell A, Feng C, Feng M, Fenton MJ, Fenyuk AB, Ferguson SW, Ferrando J, Ferrante A, Ferrari A, Ferrari P, Ferrari R, Ferreira de Lima DE, Ferrer A, Ferrere D, Ferretti C, Fiedler F, Filipčič A, Filthaut F, Finelli KD, Fiolhais MCN, Fiorini L, Fischer F, Fisher WC, Fleck I, Fleischmann P, Flick T, Flierl BM, Flores L, Flores Castillo LR, Follega FM, Fomin N, Foo JH, Forcolin GT, Formica A, Förster FA, Forti AC, Foster AG, Foti MG, Fournier D, Fox H, Francavilla P, Francescato S, Franchini M, Franchino S, Francis D, Franconi L, Franklin M, Fray AN, Freeman PM, Freund B, Freund WS, Freundlich EM, Frizzell DC, Froidevaux D, Frost JA, Fukunaga C, Fullana Torregrosa E, Fusayasu T, Fuster J, Gabrielli A, Gabrielli A, Gadatsch S, Gadow P, Gagliardi G, Gagnon LG, Galhardo B, Gallardo GE, Gallas EJ, Gallop BJ, Galster G, Gamboa Goni R, Gan KK, Ganguly S, Gao J, Gao Y, Gao YS, García C, García Navarro JE, García Pascual JA, Garcia-Argos C, Garcia-Sciveres M, Gardner RW, Garelli N, Gargiulo S, Garner CA, Garonne V, Gasiorowski SJ, Gaspar P, Gaudiello A, Gaudio G, Gavrilenko IL, Gavrilyuk A, Gay C, Gaycken G, Gazis EN, Geanta AA, Gee CM, Gee CNP, Geisen J, Geisen M, Gemme C, Genest MH, Geng C, Gentile S, George S, Geralis T, Gerlach LO, Gessinger-Befurt P, Gessner G, Ghasemi S, Ghasemi Bostanabad M, Ghneimat M, Ghosh A, Ghosh A, Giacobbe B, Giagu S, Giangiacomi N, Giannetti P, Giannini A, Giannini G, Gibson SM, Gignac M, Gillberg D, Gilles G, Gingrich DM, Giordani MP, Giraud PF, Giugliarelli G, Giugni D, Giuli F, Gkaitatzis S, Gkialas I, Gkougkousis EL, Gkountoumis P, Gladilin LK, Glasman C, Glatzer J, Glaysher PCF, Glazov A, Gledhill GR, Gnesi I, Goblirsch-Kolb M, Godin D, Goldfarb S, Golling T, Golubkov D, Gomes A, Goncalves Gama R, Gonçalo R, Gonella G, Gonella L, Gongadze A, Gonnella F, Gonski JL, González de la Hoz S, Gonzalez Fernandez S, Gonzalez Renteria C, Gonzalez-Sevilla S, Gonzalvo Rodriguez GR, Goossens L, Gorasia NA, Gorbounov PA, Gordon HA, Gorini B, Gorini E, Gorišek A, Goshaw AT, Gostkin MI, Gottardo CA, Gouighri M, Goussiou AG, Govender N, Goy C, Gozani E, Grabowska-Bold I, Graham EC, Gramling J, Gramstad E, Grancagnolo S, Grandi M, Gratchev V, Gravila PM, Gravili FG, Gray C, Gray HM, Grefe C, Gregersen K, Gregor IM, Grenier P, Grevtsov K, Grieco C, Grieser NA, Grillo AA, Grimm K, Grinstein S, Grivaz JF, Groh S, Gross E, Grosse-Knetter J, Grout ZJ, Grud C, Grummer A, Guan L, Guan W, Gubbels C, Guenther J, Guerguichon A, Guerrero Rojas JGR, Guescini F, Guest D, Gugel R, Guillemin T, Guindon S, Gul U, Guo J, Guo W, Guo Y, Guo Z, Gupta R, Gurbuz S, Gustavino G, Guth M, Gutierrez P, Gutschow C, Guyot C, Gwenlan C, Gwilliam CB, Haas A, Haber C, Hadavand HK, Hadef A, Haleem M, Haley J, Halladjian G, Hallewell GD, Hamacher K, Hamal P, Hamano K, Hamdaoui H, Hamer M, Hamity GN, Han K, Han L, Han S, Han YF, Hanagaki K, Hance M, Handl DM, Haney B, Hankache R, Hansen E, Hansen JB, Hansen JD, Hansen MC, Hansen PH, Hanson EC, Hara K, Harenberg T, Harkusha S, Harrison PF, Hartman NM, Hartmann NM, Hasegawa Y, Hasib A, Hassani S, Haug S, Hauser R, Havener LB, Havranek M, Hawkes CM, Hawkings RJ, Hayden D, Hayes C, Hayes RL, Hays CP, Hays JM, Hayward HS, Haywood SJ, He F, Heath MP, Hedberg V, Heer S, Heidegger KK, Heidorn WD, Heilman J, Heim S, Heim T, Heinemann B, Heinrich JJ, Heinrich L, Hejbal J, Helary L, Held A, Hellesund S, Helling CM, Hellman S, Helsens C, Henderson RCW, Heng Y, Henkelmann L, Henriques Correia AM, Herde H, Hernández Jiménez Y, Herr H, Herrmann MG, Herrmann T, Herten G, Hertenberger R, Hervas L, Herwig TC, Hesketh GG, Hessey NP, Hibi H, Higashida A, Higashino S, Higón-Rodriguez E, Hildebrand K, Hill JC, Hill KK, Hiller KH, Hillier SJ, Hils M, Hinchliffe I, Hinterkeuser F, Hirose M, Hirose S, Hirschbuehl D, Hiti B, Hladik O, Hlaluku DR, Hobbs J, Hod N, Hodgkinson MC, Hoecker A, Hohn D, Hohov D, Holm T, Holmes TR, Holzbock M, Hommels LBAH, Honda S, Hong TM, Honig JC, Hönle A, Hooberman BH, Hopkins WH, Horii Y, Horn P, Horyn LA, Hou S, Hoummada A, Howarth J, Hoya J, Hrabovsky M, Hrdinka J, Hristova I, Hrivnac J, Hrynevich A, Hryn'ova T, Hsu PJ, Hsu SC, Hu Q, Hu S, Hu YF, Huang DP, Huang Y, Huang Y, Hubacek Z, Hubaut F, Huebner M, Huegging F, Huffman TB, Huhtinen M, Hunter RFH, Huo P, Huseynov N, Huston J, Huth J, Hyneman R, Hyrych S, Iacobucci G, Iakovidis G, Ibragimov I, Iconomidou-Fayard L, Iengo P, Ignazzi R, Igonkina O, Iguchi R, Iizawa T, Ikegami Y, Ikeno M, Iliadis D, Ilic N, Iltzsche F, Introzzi G, Iodice M, Iordanidou K, Ippolito V, Isacson MF, Ishino M, Islam W, Issever C, Istin S, Ito F, Iturbe Ponce JM, Iuppa R, Ivina A, Iwasaki H, Izen JM, Izzo V, Jacka P, Jackson P, Jacobs RM, Jaeger BP, Jain V, Jäkel G, Jakobi KB, Jakobs K, Jakoubek T, Jamieson J, Janas KW, Jansky R, Janus M, Janus PA, Jarlskog G, Jaspan AE, Javadov N, Javůrek T, Javurkova M, Jeanneau F, Jeanty L, Jejelava J, Jelinskas A, Jenni P, Jeong N, Jézéquel S, Ji H, Jia J, Jiang H, Jiang Y, Jiang Z, Jiggins S, Jimenez Morales FA, Jimenez Pena J, Jin S, Jinaru A, Jinnouchi O, Jivan H, Johansson P, Johns KA, Johnson CA, Jones RWL, Jones SD, Jones S, Jones TJ, Jongmanns J, Jorge PM, Jovicevic J, Ju X, Junggeburth JJ, Juste Rozas A, Kaczmarska A, Kado M, Kagan H, Kagan M, Kahn A, Kahra C, Kaji T, Kajomovitz E, Kalderon CW, Kaluza A, Kamenshchikov A, Kaneda M, Kang NJ, Kang S, Kano Y, Kanzaki J, Kaplan LS, Kar D, Karava K, Kareem MJ, Karkanias I, Karpov SN, Karpova ZM, Kartvelishvili V, Karyukhin AN, Kastanas A, Kato C, Katzy J, Kawade K, Kawagoe K, Kawaguchi T, Kawamoto T, Kawamura G, Kay EF, Kazanin VF, Keeler R, Kehoe R, Keller JS, Kellermann E, Kelsey D, Kempster JJ, Kendrick J, Kennedy KE, Kepka O, Kersten S, Kerševan BP, Ketabchi Haghighat S, Khader M, Khalil-Zada F, Khandoga M, Khanov A, Kharlamov AG, Kharlamova T, Khoda EE, Khodinov A, Khoo TJ, Khramov E, Khubua J, Kido S, Kiehn M, Kilby CR, Kim E, Kim YK, Kimura N, Kind OM, King BT, Kirchmeier D, Kirk J, Kiryunin AE, Kishimoto T, Kisliuk DP, Kitali V, Kivernyk O, Klapdor-Kleingrothaus T, Klassen M, Klein C, Klein MH, Klein M, Klein U, Kleinknecht K, Klimek P, Klimentov A, Klingl T, Klioutchnikova T, Klitzner FF, Kluit P, Kluth S, Kneringer E, Knoops EBFG, Knue A, Kobayashi D, Kobayashi T, Kobel M, Kocian M, Kodama T, Kodys P, Koeck DM, Koenig PT, Koffas T, Köhler NM, Kolb M, Koletsou I, Komarek T, Kondo T, Köneke K, Kong AXY, König AC, Kono T, Konstantinides V, Konstantinidis N, Konya B, Kopeliansky R, Koperny S, Korcyl K, Kordas K, Koren G, Korn A, Korolkov I, Korolkova EV, Korotkova N, Kortner O, Kortner S, Kostyukhin VV, Kotsokechagia A, Kotwal A, Koulouris A, Kourkoumeli-Charalampidi A, Kourkoumelis C, Kourlitis E, Kouskoura V, Kowalewska AB, Kowalewski R, Kozanecki W, Kozhin AS, Kramarenko VA, Kramberger G, Krasnopevtsev D, Krasny MW, Krasznahorkay A, Krauss D, Kremer JA, Kretzschmar J, Krieger P, Krieter F, Krishnan A, Krizka K, Kroeninger K, Kroha H, Kroll J, Kroll J, Krowpman KS, Kruchonak U, Krüger H, Krumnack N, Kruse MC, Krzysiak JA, Kubota T, Kuchinskaia O, Kuday S, Kuechler D, Kuechler JT, Kuehn S, Kugel A, Kuhl T, Kukhtin V, Kukla R, Kulchitsky Y, Kuleshov S, Kulinich YP, Kuna M, Kunigo T, Kupco A, Kupfer T, Kuprash O, Kurashige H, Kurchaninov LL, Kurochkin YA, Kurova A, Kurth MG, Kuwertz ES, Kuze M, Kvam AK, Kvita J, Kwan T, La Rotonda L, La Ruffa F, Lacasta C, Lacava F, Lack DPJ, Lacker H, Lacour D, Ladygin E, Lafaye R, Laforge B, Lagouri T, Lai S, Lakomiec IK, Lammers S, Lampl W, Lampoudis C, Lançon E, Landgraf U, Landon MPJ, Lanfermann MC, Lang VS, Lange JC, Langenberg RJ, Lankford AJ, Lanni F, Lantzsch K, Lanza A, Lapertosa A, Laplace S, Laporte JF, Lari T, Lasagni Manghi F, Lassnig M, Lau TS, Laudrain A, Laurier A, Lavorgna M, Lawlor SD, Lazzaroni M, Le B, Le Guirriec E, Lebedev A, LeBlanc M, LeCompte T, Ledroit-Guillon F, Lee ACA, Lee CA, Lee GR, Lee L, Lee SC, Lee S, Lefebvre B, Lefebvre HP, Lefebvre M, Leggett C, Lehmann K, Lehmann N, Lehmann Miotto G, Leight WA, Leisos A, Leite MAL, Leitgeb CE, Leitner R, Lellouch D, Leney KJC, Lenz T, Leone R, Leone S, Leonidopoulos C, Leopold A, Leroy C, Les R, Lester CG, Levchenko M, Levêque J, Levin D, Levinson LJ, Lewis DJ, Li B, Li B, Li CQ, Li F, Li H, Li H, Li J, Li K, Li L, Li M, Li Q, Li QY, Li S, Li X, Li Y, Li Z, Li Z, Liang Z, Liberti B, Liblong A, Lie K, Lim S, Lin CY, Lin K, Lin TH, Linck RA, Lindley RE, Lindon JH, Lionti AL, Lipeles E, Lipniacka A, Liss TM, Lister A, Little JD, Liu B, Liu BX, Liu HB, Liu H, Liu JB, Liu JKK, Liu K, Liu M, Liu P, Liu Y, Liu Y, Liu YL, Liu YW, Livan M, Lleres A, Llorente Merino J, Lloyd SL, Lo CY, Lobodzinska EM, Loch P, Loffredo S, Lohse T, Lohwasser K, Lokajicek M, Long JD, Long RE, Longo L, Looper KA, Lopez Paz I, Lopez Solis A, Lorenz J, Lorenzo Martinez N, Lory AM, Lösel PJ, Lösle A, Lou X, Lou X, Lounis A, Love J, Love PA, Lozano Bahilo JJ, Lu M, Lu YJ, Lubatti HJ, Luci C, Lucotte A, Luedtke C, Luehring F, Luise I, Luminari L, Lund-Jensen B, Lutz MS, Lynn D, Lyons H, Lysak R, Lytken E, Lyu F, Lyubushkin V, Lyubushkina T, Ma H, Ma LL, Ma Y, Maccarrone G, Macchiolo A, Macdonald CM, Machado Miguens J, Madaffari D, Madar R, Mader WF, Madugoda Ralalage Don M, Madysa N, Maeda J, Maeno T, Maerker M, Magerl V, Magini N, Magro J, Mahon DJ, Maidantchik C, Maier T, Maio A, Maj K, Majersky O, Majewski S, Makida Y, Makovec N, Malaescu B, Malecki P, Maleev VP, Malek F, Mallik U, Malon D, Malone C, Maltezos S, Malyukov S, Mamuzic J, Mancini G, Mandić I, Manhaes de Andrade Filho L, Maniatis IM, Manjarres Ramos J, Mankinen KH, Mann A, Manousos A, Mansoulie B, Manthos I, Manzoni S, Marantis A, Marceca G, Marchese L, Marchiori G, Marcisovsky M, Marcoccia L, Marcon C, Marin Tobon CA, Marjanovic M, Marshall Z, Martensson MUF, Marti-Garcia S, Martin CB, Martin TA, Martin VJ, Martin Dit Latour B, Martinelli L, Martinez M, Martinez Outschoorn VI, Martin-Haugh S, Martoiu VS, Martyniuk AC, Marzin A, Maschek SR, Masetti L, Mashimo T, Mashinistov R, Masik J, Maslennikov AL, Massa L, Massarotti P, Mastrandrea P, Mastroberardino A, Masubuchi T, Matakias D, Matic A, Matsuzawa N, Mättig P, Maurer J, Maček B, Maximov DA, Mazini R, Maznas I, Mazza SM, Mc Kee SP, McCarthy TG, McCormack WP, McDonald EF, Mcfayden JA, Mchedlidze G, McKay MA, McLean KD, McMahon SJ, McNamara PC, McNicol CJ, McPherson RA, Mdhluli JE, Meadows ZA, Meehan S, Megy T, Mehlhase S, Mehta A, Meideck T, Meirose B, Melini D, Mellado Garcia BR, Mellenthin JD, Melo M, Meloni F, Melzer A, Menary SB, Mendes Gouveia ED, Meng L, Meng XT, Menke S, Meoni E, Mergelmeyer S, Merkt SAM, Merlassino C, Mermod P, Merola L, Meroni C, Merz G, Meshkov O, Meshreki JKR, Messina A, Metcalfe J, Mete AS, Meyer C, Meyer JP, Meyer Zu Theenhausen H, Miano F, Michetti M, Middleton RP, Mijović L, Mikenberg G, Mikestikova M, Mikuž M, Mildner H, Milesi M, Milic A, Milke CD, Miller DW, Milov A, Milstead DA, Mina RA, Minaenko AA, Miñano Moya M, Minashvili IA, Mincer AI, Mindur B, Mineev M, Minegishi Y, Mir LM, Mirto A, Mistry KP, Mitani T, Mitrevski J, Mitsou VA, Mittal M, Miu O, Miucci A, Miyagawa PS, Mizukami A, Mjörnmark JU, Mkrtchyan T, Mlynarikova M, Moa T, Mochizuki K, Mogg P, Mohapatra S, Moles-Valls R, Mondragon MC, Mönig K, Monk J, Monnier E, Montalbano A, Montejo Berlingen J, Montella M, Monticelli F, Monzani S, Morange N, Moreno D, Moreno Llácer M, Moreno Martinez C, Morettini P, Morgenstern M, Morgenstern S, Mori D, Morii M, Morinaga M, Morisbak V, Morley AK, Mornacchi G, Morris AP, Morvaj L, Moschovakos P, Moser B, Mosidze M, Moskalets T, Moss HJ, Moss J, Moyse EJW, Muanza S, Mueller J, Mueller RSP, Muenstermann D, Mullier GA, Mungo DP, Munoz Martinez JL, Munoz Sanchez FJ, Murin P, Murray WJ, Murrone A, Muškinja M, Mwewa C, Myagkov AG, Myers AA, Myers J, Myska M, Nachman BP, Nackenhorst O, Nag AN, Nagai K, Nagano K, Nagasaka Y, Nagle JL, Nagy E, Nairz AM, Nakahama Y, Nakamura K, Nakamura T, Nanjo H, Napolitano F, Naranjo Garcia RF, Narayan R, Naryshkin I, Naumann T, Navarro G, Nechaeva PY, Nechansky F, Neep TJ, Negri A, Negrini M, Nellist C, Nelson ME, Nemecek S, Nessi M, Neubauer MS, Neuhaus F, Neumann M, Newhouse R, Newman PR, Ng CW, Ng YS, Ng YWY, Ngair B, Nguyen HDN, Nguyen Manh T, Nibigira E, Nickerson RB, Nicolaidou R, Nielsen DS, Nielsen J, Nikiforou N, Nikolaenko V, Nikolic-Audit I, Nikolopoulos K, Nilsson P, Nindhito HR, Ninomiya Y, Nisati A, Nishu N, Nisius R, Nitsche I, Nitta T, Nobe T, Noguchi Y, Nomidis I, Nomura MA, Nordberg M, Novak T, Novgorodova O, Novotny R, Nozka L, Ntekas K, Nurse E, Oakham FG, Oberlack H, Ocariz J, Ochi A, Ochoa I, Ochoa-Ricoux JP, O'Connor K, Oda S, Odaka S, Oerdek S, Ogrodnik A, Oh A, Oh SH, Ohm CC, Oide H, Ojeda ML, Okawa H, Okazaki Y, O'Keefe MW, Okumura Y, Okuyama T, Olariu A, Oleiro Seabra LF, Olivares Pino SA, Oliveira Damazio D, Oliver JL, Olsson MJR, Olszewski A, Olszowska J, O'Neil DC, O'neill AP, Onofre A, Onyisi PUE, Oppen H, Oreglia MJ, Orellana GE, Orestano D, Orlando N, Orr RS, O'Shea V, Ospanov R, Otero Y Garzon G, Otono H, Ott PS, Ottino GJ, Ouchrif M, Ouellette J, Ould-Saada F, Ouraou A, Ouyang Q, Owen M, Owen RE, Ozcan VE, Ozturk N, Pacalt J, Pacey HA, Pachal K, Pacheco Pages A, Padilla Aranda C, Pagan Griso S, Paganini M, Palacino G, Palazzo S, Palestini S, Palka M, Pallin D, Palni P, Panagoulias I, Pandini CE, Panduro Vazquez JG, Pani P, Panizzo G, Paolozzi L, Papadatos C, Papageorgiou K, Parajuli S, Paramonov A, Paredes Hernandez D, Paredes Saenz SR, Parida B, Park TH, Parker AJ, Parker MA, Parodi F, Parrish EW, Parsons JA, Parzefall U, Pascual Dominguez L, Pascuzzi VR, Pasner JMP, Pasquali F, Pasqualucci E, Passaggio S, Pastore F, Pasuwan P, Pataraia S, Pater JR, Pathak A, Patton J, Pauly T, Pearkes J, Pearson B, Pedersen M, Pedraza Diaz L, Pedro R, Peiffer T, Peleganchuk SV, Penc O, Peng H, Peralva BS, Perego MM, Pereira Peixoto AP, Pereira Sanchez L, Perepelitsa DV, Peri F, Perini L, Pernegger H, Perrella S, Perrevoort A, Peters K, Peters RFY, Petersen BA, Petersen TC, Petit E, Petridis A, Petridou C, Petrucci F, Pettee M, Pettersson NE, Petukhova K, Peyaud A, Pezoa R, Pezzotti L, Pham T, Phillips FH, Phillips PW, Phipps MW, Piacquadio G, Pianori E, Picazio A, Pickles RH, Piegaia R, Pietreanu D, Pilcher JE, Pilkington AD, Pinamonti M, Pinfold JL, Pitman Donaldson C, Pitt M, Pizzimento L, Pleier MA, Pleskot V, Plotnikova E, Podberezko P, Poettgen R, Poggi R, Poggioli L, Pogrebnyak I, Pohl D, Pokharel I, Polesello G, Poley A, Policicchio A, Polifka R, Polini A, Pollard CS, Polychronakos V, Ponomarenko D, Pontecorvo L, Popa S, Popeneciu GA, Portales L, Portillo Quintero DM, Pospisil S, Potamianos K, Potrap IN, Potter CJ, Potti H, Poulsen T, Poveda J, Powell TD, Pownall G, Pozo Astigarraga ME, Pralavorio P, Prell S, Price D, Primavera M, Prince S, Proffitt ML, Proklova N, Prokofiev K, Prokoshin F, Protopopescu S, Proudfoot J, Przybycien M, Pudzha D, Puri A, Puzo P, Qian J, Qin Y, Quadt A, Queitsch-Maitland M, Qureshi A, Racko M, Ragusa F, Rahal G, Raine JA, Rajagopalan S, Ramirez Morales A, Ran K, Rashid T, Raspopov S, Rauch DM, Rauscher F, Rave S, Ravina B, Ravinovich I, Rawling JH, Raymond M, Read AL, Readioff NP, Reale M, Rebuzzi DM, Redlinger G, Reeves K, Rehnisch L, Reichert J, Reikher D, Reiss A, Rej A, Rembser C, Renardi A, Renda M, Rescigno M, Resconi S, Resseguie ED, Rettie S, Reynolds B, Reynolds E, Rezanova OL, Reznicek P, Ricci E, Richter R, Richter S, Richter-Was E, Ricken O, Ridel M, Rieck P, Rifki O, Rijssenbeek M, Rimoldi A, Rimoldi M, Rinaldi L, Ripellino G, Riu I, Rivera Vergara JC, Rizatdinova F, Rizvi E, Rizzi C, Roberts RT, Robertson SH, Robin M, Robinson D, Robles Gajardo CM, Robles Manzano M, Robson A, Rocchi A, Rocco E, Roda C, Rodriguez Bosca S, Rodriguez Perez A, Rodriguez Rodriguez D, Rodríguez Vera AM, Roe S, Røhne O, Röhrig R, Rojas RA, Roland B, Roland CPA, Roloff J, Romaniouk A, Romano M, Rompotis N, Ronzani M, Roos L, Rosati S, Rosin G, Rosser BJ, Rossi E, Rossi E, Rossi E, Rossi LP, Rossini L, Rosten R, Rotaru M, Rottler B, Rousseau D, Rovelli G, Roy A, Roy D, Rozanov A, Rozen Y, Ruan X, Rühr F, Ruiz-Martinez A, Rummler A, Rurikova Z, Rusakovich NA, Russell HL, Rustige L, Rutherfoord JP, Rüttinger EM, Rybar M, Rybkin G, Rye EB, Ryzhov A, Sabater Iglesias JA, Sabatini P, Sacerdoti S, Sadrozinski HFW, Sadykov R, Safai Tehrani F, Safarzadeh Samani B, Safdari M, Saha P, Saha S, Sahinsoy M, Sahu A, Saimpert M, Saito M, Saito T, Sakamoto H, Salamani D, Salamanna G, Salazar Loyola JE, Salnikov A, Salt J, Salvador Salas A, Salvatore D, Salvatore F, Salvucci A, Salzburger A, Samarati J, Sammel D, Sampsonidis D, Sampsonidou D, Sánchez J, Sanchez Pineda A, Sandaker H, Sander CO, Sanderswood IG, Sandhoff M, Sandoval C, Sankey DPC, Sannino M, Sano Y, Sansoni A, Santoni C, Santos H, Santpur SN, Santra A, Sapronov A, Saraiva JG, Sasaki O, Sato K, Sauerburger F, Sauvan E, Savard P, Sawada R, Sawyer C, Sawyer L, Sbarra C, Sbrizzi A, Scanlon T, Schaarschmidt J, Schacht P, Schachtner BM, Schaefer D, Schaefer L, Schaeffer J, Schaepe S, Schäfer U, Schaffer AC, Schaile D, Schamberger RD, Scharmberg N, Schegelsky VA, Scheirich D, Schenck F, Schernau M, Schiavi C, Schildgen LK, Schillaci ZM, Schioppa EJ, Schioppa M, Schleicher KE, Schlenker S, Schmidt-Sommerfeld KR, Schmieden K, Schmitt C, Schmitt S, Schmitz S, Schmoeckel JC, Schoeffel L, Schoening A, Scholer PG, Schopf E, Schott M, Schouwenberg JFP, Schovancova J, Schramm S, Schroeder F, Schulte A, Schultz-Coulon HC, Schumacher M, Schumm BA, Schune P, Schwartzman A, Schwarz TA, Schwemling P, Schwienhorst R, Sciandra A, Sciolla G, Scodeggio M, Scornajenghi M, Scuri F, Scutti F, Scyboz LM, Sebastiani CD, Seema P, Seidel SC, Seiden A, Seidlitz BD, Seiss T, Seitz C, Seixas JM, Sekhniaidze G, Sekula SJ, Semprini-Cesari N, Sen S, Serfon C, Serin L, Serkin L, Sessa M, Severini H, Sevova S, Sforza F, Sfyrla A, Shabalina E, Shahinian JD, Shaikh NW, Shaked Renous D, Shan LY, Shapiro M, Sharma A, Sharma AS, Shatalov PB, Shaw K, Shaw SM, Shehade M, Shen Y, Sherman AD, Sherwood P, Shi L, Shimizu S, Shimmin CO, Shimogama Y, Shimojima M, Shipsey IPJ, Shirabe S, Shiyakova M, Shlomi J, Shmeleva A, Shochet MJ, Shojaii J, Shope DR, Shrestha S, Shrif EM, Shulga E, Sicho P, Sickles AM, Sidebo PE, Sideras Haddad E, Sidiropoulou O, Sidoti A, Siegert F, Sijacki D, Silva M, Silva Oliveira MV, Silverstein SB, Simion S, Simoniello R, Simpson-Allsop CJ, Simsek S, Sinervo P, Sinetckii V, Singh S, Sioli M, Siral I, Sivoklokov SY, Sjölin J, Skorda E, Skubic P, Slawinska M, Sliwa K, Slovak R, Smakhtin V, Smart BH, Smiesko J, Smirnov N, Smirnov SY, Smirnov Y, Smirnova LN, Smirnova O, Smith JW, Smizanska M, Smolek K, Smykiewicz A, Snesarev AA, Snoek HL, Snyder IM, Snyder S, Sobie R, Soffer A, Søgaard A, Sohns F, Solans Sanchez CA, Soldatov EY, Soldevila U, Solodkov AA, Soloshenko A, Solovyanov OV, Solovyev V, Sommer P, Son H, Song W, Song WY, Sopczak A, Sopio AL, Sopkova F, Sotiropoulou CL, Sottocornola S, Soualah R, Soukharev AM, South D, Spagnolo S, Spalla M, Spangenberg M, Spanò F, Sperlich D, Spieker TM, Spigo G, Spina M, Spiteri DP, Spousta M, Stabile A, Stamas BL, Stamen R, Stamenkovic M, Stanecka E, Stanislaus B, Stanitzki MM, Stankaityte M, Stapf B, Starchenko EA, Stark GH, Stark J, Staroba P, Starovoitov P, Stärz S, Staszewski R, Stavropoulos G, Stegler M, Steinberg P, Steinhebel AL, Stelzer B, Stelzer HJ, Stelzer-Chilton O, Stenzel H, Stevenson TJ, Stewart GA, Stockton MC, Stoicea G, Stolarski M, Stonjek S, Straessner A, Strandberg J, Strandberg S, Strauss M, Strizenec P, Ströhmer R, Strom DM, Stroynowski R, Strubig A, Stucci SA, Stugu B, Stupak J, Styles NA, Su D, Su W, Suchek S, Sulin VV, Sullivan MJ, Sultan DMS, Sultansoy S, Sumida T, Sun S, Sun X, Suruliz K, Suster CJE, Sutton MR, Suzuki S, Svatos M, Swiatlowski M, Swift SP, Swirski T, Sydorenko A, Sykora I, Sykora M, Sykora T, Ta D, Tackmann K, Taenzer J, Taffard A, Tafirout R, Takashima R, Takeda K, Takeshita T, Takeva EP, Takubo Y, Talby M, Talyshev AA, Tamir NM, Tanaka J, Tanaka R, Tapia Araya S, Tapprogge S, Tarek Abouelfadl Mohamed A, Tarem S, Tariq K, Tarna G, Tartarelli GF, Tas P, Tasevsky M, Tashiro T, Tassi E, Tavares Delgado A, Tayalati Y, Taylor AJ, Taylor GN, Taylor W, Teagle H, Tee AS, Teixeira De Lima R, Teixeira-Dias P, Ten Kate H, Teoh JJ, Terada S, Terashi K, Terron J, Terzo S, Testa M, Teuscher RJ, Thais SJ, Themistokleous N, Theveneaux-Pelzer T, Thiele F, Thomas DW, Thomas JO, Thomas JP, Thompson PD, Thomsen LA, Thomson E, Thorpe EJ, Ticse Torres RE, Tikhomirov VO, Tikhonov YA, Timoshenko S, Tipton P, Tisserant S, Todome K, Todorova-Nova S, Todt S, Tojo J, Tokár S, Tokushuku K, Tolley E, Tomiwa KG, Tomoto M, Tompkins L, Tornambe P, Torrence E, Torres H, Torró Pastor E, Tosciri C, Toth J, Tovey DR, Traeet A, Treado CJ, Trefzger T, Tresoldi F, Tricoli A, Trigger IM, Trincaz-Duvoid S, Trischuk DA, Trischuk W, Trocmé B, Trofymov A, Troncon C, Trovato F, Truong L, Trzebinski M, Trzupek A, Tsai F, Tseng JCL, Tsiareshka PV, Tsirigotis A, Tsiskaridze V, Tskhadadze EG, Tsopoulou M, Tsukerman II, Tsulaia V, Tsuno S, Tsybychev D, Tu Y, Tudorache A, Tudorache V, Tulbure TT, Tuna AN, Turchikhin S, Turgeman D, Turk Cakir I, Turner RJ, Turra R, Tuts PM, Tzamarias S, Tzovara E, Ucchielli G, Uchida K, Ukegawa F, Unal G, Undrus A, Unel G, Ungaro FC, Unno Y, Uno K, Urban J, Urquijo P, Usai G, Uysal Z, Vacek V, Vachon B, Vadla KOH, Vaidya A, Valderanis C, Valdes Santurio E, Valente M, Valentinetti S, Valero A, Valéry L, Vallance RA, Vallier A, Valls Ferrer JA, Van Daalen TR, Van Gemmeren P, Van Vulpen I, Vanadia M, Vandelli W, Vandenbroucke M, Vandewall ER, Vaniachine A, Vannicola D, Vari R, Varnes EW, Varni C, Varol T, Varouchas D, Varvell KE, Vasile ME, Vasquez GA, Vazeille F, Vazquez Furelos D, Vazquez Schroeder T, Veatch J, Vecchio V, Veen MJ, Veloce LM, Veloso F, Veneziano S, Ventura A, Venturi N, Verbytskyi A, Vercesi V, Verducci M, Vergel Infante CM, Vergis C, Verkerke W, Vermeulen AT, Vermeulen JC, Vernieri C, Vetterli MC, Viaux Maira N, Vickey T, Vickey Boeriu OE, Viehhauser GHA, Vigani L, Villa M, Villaplana Perez M, Vilucchi E, Vincter MG, Virdee GS, Vishwakarma A, Vittori C, Vivarelli I, Vogel M, Vokac P, von Buddenbrock SE, Von Toerne E, Vorobel V, Vorobev K, Vos M, Vossebeld JH, Vozak M, Vranjes N, Vranjes Milosavljevic M, Vrba V, Vreeswijk M, Vuillermet R, Vukotic I, Wada S, Wagner P, Wagner W, Wagner-Kuhr J, Wahdan S, Wahlberg H, Wakasa R, Walbrecht VM, Walder J, Walker R, Walker SD, Walkowiak W, Wallangen V, Wang AM, Wang AZ, Wang C, Wang F, Wang H, Wang H, Wang J, Wang J, Wang P, Wang Q, Wang RJ, Wang R, Wang R, Wang SM, Wang WT, Wang W, Wang WX, Wang Y, Wang Z, Wanotayaroj C, Warburton A, Ward CP, Wardrope DR, Warrack N, Washbrook A, Watson AT, Watson MF, Watts G, Waugh BM, Webb AF, Weber C, Weber MS, Weber SA, Weber SM, Weidberg AR, Weingarten J, Weirich M, Weiser C, Wells PS, Wenaus T, Wengler T, Wenig S, Wermes N, Werner MD, Wessels M, Weston TD, Whalen K, Whallon NL, Wharton AM, White AS, White A, White MJ, Whiteson D, Whitmore BW, Wiedenmann W, Wiel C, Wielers M, Wieseotte N, Wiglesworth C, Wiik-Fuchs LAM, Wilkens HG, Wilkins LJ, Williams HH, Williams S, Willis C, Willocq S, Wingerter-Seez I, Winkels E, Winklmeier F, Winter BT, Wittgen M, Wobisch M, Wolf A, Wolf TMH, Wolff R, Wölker R, Wollrath J, Wolter MW, Wolters H, Wong VWS, Woods NL, Worm SD, Wosiek BK, Woźniak KW, Wraight K, Wu SL, Wu X, Wu Y, Wyatt TR, Wynne BM, Xella S, Xi Z, Xia L, Xiao X, Xiotidis I, Xu D, Xu H, Xu H, Xu L, Xu T, Xu W, Xu Z, Xu Z, Yabsley B, Yacoob S, Yajima K, Yallup DP, Yamaguchi N, Yamaguchi Y, Yamamoto A, Yamatani M, Yamazaki T, Yamazaki Y, Yan J, Yan Z, Yang HJ, Yang HT, Yang S, Yang T, Yang X, Yang Y, Yang Z, Yao WM, Yap YC, Yasu Y, Yatsenko E, Ye H, Ye J, Ye S, Yeletskikh I, Yexley MR, Yigitbasi E, Yorita K, Yoshihara K, Young CJS, Young C, Yu J, Yuan R, Yue X, Zaazoua M, Zabinski B, Zacharis G, Zaffaroni E, Zahreddine J, Zaitsev AM, Zakareishvili T, Zakharchuk N, Zambito S, Zanzi D, Zaripovas DR, Zeißner SV, Zeitnitz C, Zemaityte G, Zeng JC, Zenin O, Ženiš T, Zerwas D, Zgubič M, Zhang B, Zhang DF, Zhang G, Zhang H, Zhang J, Zhang K, Zhang L, Zhang L, Zhang M, Zhang R, Zhang S, Zhang X, Zhang X, Zhang Y, Zhang Z, Zhang Z, Zhao P, Zhao Z, Zhemchugov A, Zheng Z, Zhong D, Zhou B, Zhou C, Zhou H, Zhou MS, Zhou M, Zhou N, Zhou Y, Zhu CG, Zhu C, Zhu HL, Zhu H, Zhu J, Zhu Y, Zhuang X, Zhukov K, Zhulanov V, Zieminska D, Zimine NI, Zimmermann S, Zinonos Z, Ziolkowski M, Živković L, Zobernig G, Zoccoli A, Zoch K, Zorbas TG, Zou R, Zwalinski L. Longitudinal Flow Decorrelations in Xe+Xe Collisions at sqrt[s_{NN}]=5.44 TeV with the ATLAS Detector. PHYSICAL REVIEW LETTERS 2021; 126:122301. [PMID: 33834811 DOI: 10.1103/physrevlett.126.122301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/14/2020] [Revised: 06/16/2020] [Accepted: 02/12/2021] [Indexed: 06/12/2023]
Abstract
The first measurement of longitudinal decorrelations of harmonic flow amplitudes v_{n} for n=2-4 in Xe+Xe collisions at sqrt[s_{NN}]=5.44 TeV is obtained using 3 μb^{-1} of data with the ATLAS detector at the LHC. The decorrelation signal for v_{3} and v_{4} is found to be nearly independent of collision centrality and transverse momentum (p_{T}) requirements on final-state particles, but for v_{2} a strong centrality and p_{T} dependence is seen. When compared with the results from Pb+Pb collisions at sqrt[s_{NN}]=5.02 TeV, the longitudinal decorrelation signal in midcentral Xe+Xe collisions is found to be larger for v_{2}, but smaller for v_{3}. Current hydrodynamic models reproduce the ratios of the v_{n} measured in Xe+Xe collisions to those in Pb+Pb collisions but fail to describe the magnitudes and trends of the ratios of longitudinal flow decorrelations between Xe+Xe and Pb+Pb. The results on the system-size dependence provide new insights and an important lever arm to separate effects of the longitudinal structure of the initial state from other early and late time effects in heavy-ion collisions.
Collapse
|
120
|
Aad G, Abbott B, Abbott DC, Abed Abud A, Abeling K, Abhayasinghe DK, Abidi SH, AbouZeid OS, Abraham NL, Abramowicz H, Abreu H, Abulaiti Y, Acharya BS, Achkar B, Adam L, Adam Bourdarios C, Adamczyk L, Adamek L, Adelman J, Adiguzel A, Adorni S, Adye T, Affolder AA, Afik Y, Agapopoulou C, Agaras MN, Aggarwal A, Agheorghiesei C, Aguilar-Saavedra JA, Ahmad A, Ahmadov F, Ahmed WS, Ai X, Aielli G, Akatsuka S, Akbiyik M, Åkesson TPA, Akilli E, Akimov AV, Al Khoury K, Alberghi GL, Albert J, Alconada Verzini MJ, Alderweireldt S, Aleksa M, Aleksandrov IN, Alexa C, Alexopoulos T, Alfonsi A, Alfonsi F, Alhroob M, Ali B, Ali S, Aliev M, Alimonti G, Allaire C, Allbrooke BMM, Allen BW, Allport PP, Aloisio A, Alonso F, Alpigiani C, Alunno Camelia E, Alvarez Estevez M, Alviggi MG, Amaral Coutinho Y, Ambler A, Ambroz L, Amelung C, Amidei D, Amor Dos Santos SP, Amoroso S, Amrouche CS, An F, Anastopoulos C, Andari N, Andeen T, Anders JK, Andrean SY, Andreazza A, Andrei V, Anelli CR, Angelidakis S, Angerami A, Anisenkov AV, Annovi A, Antel C, Anthony MT, Antipov E, Antonelli M, Antrim DJA, Anulli F, Aoki M, Aparisi Pozo JA, Aparo MA, Aperio Bella L, Aranzabal N, Araujo Ferraz V, Araujo Pereira R, Arcangeletti C, Arce ATH, Arguin JF, Argyropoulos S, Arling JH, Armbruster AJ, Armstrong A, Arnaez O, Arnold H, Arrubarrena Tame ZP, Artoni G, Asada H, Asai K, Asai S, Asawatavonvanich T, Asbah N, Asimakopoulou EM, Asquith L, Assahsah J, Assamagan K, Astalos R, Atkin RJ, Atkinson M, Atlay NB, Atmani H, Atmasiddha PA, Augsten K, Austrup VA, Avolio G, Ayoub MK, Azuelos G, Babal D, Bachacou H, Bachas K, Backman F, Bagnaia P, Bahmani M, Bahrasemani H, Bailey AJ, Bailey VR, Baines JT, Bakalis C, Baker OK, Bakker PJ, Bakos E, Bakshi Gupta D, Balaji S, Balasubramanian R, Baldin EM, Balek P, Balli F, Balunas WK, Balz J, Banas E, Bandieramonte M, Bandyopadhyay A, Banerjee S, Barak L, Barbe WM, Barberio EL, Barberis D, Barbero M, Barbour G, Barillari T, Barisits MS, Barkeloo J, Barklow T, Barnea R, Barnett BM, Barnett RM, Barnovska-Blenessy Z, Baroncelli A, Barone G, Barr AJ, Barranco Navarro L, Barreiro F, Barreiro Guimarães da Costa J, Barron U, Barsov S, Bartels F, Bartoldus R, Bartolini G, Barton AE, Bartos P, Basalaev A, Basan A, Bassalat A, Basso MJ, Bates RL, Batlamous S, Batley JR, Batool B, Battaglia M, Bauce M, Bauer F, Bauer P, Bawa HS, Bayirli A, Beacham JB, Beau T, Beauchemin PH, Becherer F, Bechtle P, Beck HC, Beck HP, Becker K, Becot C, Beddall A, Beddall AJ, Bednyakov VA, Bedognetti M, Bee CP, Beermann TA, Begalli M, Begel M, Behera A, Behr JK, Beisiegel F, Belfkir M, Bell AS, Bella G, Bellagamba L, Bellerive A, Bellos P, Beloborodov K, Belotskiy K, Belyaev NL, Benchekroun D, Benekos N, Benhammou Y, Benjamin DP, Benoit M, Bensinger JR, Bentvelsen S, Beresford L, Beretta M, Berge D, Bergeaas Kuutmann E, Berger N, Bergmann B, Bergsten LJ, Beringer J, Berlendis S, Bernardi G, Bernius C, Bernlochner FU, Berry T, Berta P, Berthold A, Bertram IA, Bessidskaia Bylund O, Besson N, Bethke S, Betti A, Bevan AJ, Beyer J, Bhatta S, Bhattacharya DS, Bhattarai P, Bhopatkar VS, Bi R, Bianchi RM, Biebel O, Biedermann D, Bielski R, Bierwagen K, Biesuz NV, Biglietti M, Billoud TRV, Bindi M, Bingul A, Bini C, Biondi S, Birch-Sykes CJ, Birman M, Bisanz T, Biswal JP, Biswas D, Bitadze A, Bittrich C, Bjørke K, Blazek T, Bloch I, Blocker C, Blue A, Blumenschein U, Bobbink GJ, Bobrovnikov VS, Bocchetta SS, Bogavac D, Bogdanchikov AG, Bohm C, Boisvert V, Bokan P, Bold T, Bolz AE, Bomben M, Bona M, Bonilla JS, Boonekamp M, Booth CD, Borbély AG, Borecka-Bielska HM, Borgna LS, Borisov A, Borissov G, Bortoletto D, Boscherini D, Bosman M, Bossio Sola JD, Bouaouda K, Boudreau J, Bouhova-Thacker EV, Boumediene D, Boveia A, Boyd J, Boye D, Boyko IR, Bozson AJ, Bracinik J, Brahimi N, Brandt G, Brandt O, Braren F, Brau B, Brau JE, Breaden Madden WD, Brendlinger K, Brener R, Brenner L, Brenner R, Bressler S, Brickwedde B, Briglin DL, Britton D, Britzger D, Brock I, Brock R, Brooijmans G, Brooks WK, Brost E, Bruckman de Renstrom PA, Brüers B, Bruncko D, Bruni A, Bruni G, Bruschi M, Bruscino N, Bryngemark L, Buanes T, Buat Q, Buchholz P, Buckley AG, Budagov IA, Bugge MK, Bulekov O, Bullard BA, Burch TJ, Burdin S, Burgard CD, Burger AM, Burghgrave B, Burr JTP, Burton CD, Burzynski JC, Büscher V, Buschmann E, Bussey PJ, Butler JM, Buttar CM, Butterworth JM, Butti P, Buttinger W, Buxo Vazquez CJ, Buzatu A, Buzykaev AR, Cabras G, Cabrera Urbán S, Caforio D, Cai H, Cairo VMM, Cakir O, Calace N, Calafiura P, Calderini G, Calfayan P, Callea G, Caloba LP, Caltabiano A, Calvente Lopez S, Calvet D, Calvet S, Calvet TP, Calvetti M, Camacho Toro R, Camarda S, Camarero Munoz D, Camarri P, Camerlingo MT, Cameron D, Camincher C, Campana S, Campanelli M, Camplani A, Canale V, Canesse A, Cano Bret M, Cantero J, Cao T, Cao Y, Capua M, Cardarelli R, Cardillo F, Carducci G, Carli I, Carli T, Carlino G, Carlson BT, Carlson EM, Carminati L, Carney RMD, Caron S, Carquin E, Carrá S, Carratta G, Carter JWS, Carter TM, Casado MP, Casha AF, Castiglia EG, Castillo FL, Castillo Garcia L, Castillo Gimenez V, Castro NF, Catinaccio A, Catmore JR, Cattai A, Cavaliere V, Cavasinni V, Celebi E, Celli F, Cerny K, Cerqueira AS, Cerri A, Cerrito L, Cerutti F, Cervelli A, Cetin SA, Chadi Z, Chakraborty D, Chan J, Chan WS, Chan WY, Chapman JD, Chargeishvili B, Charlton DG, Charman TP, Chatterjee M, Chau CC, Che S, Chekanov S, Chekulaev SV, Chelkov GA, Chen B, Chen C, Chen CH, Chen H, Chen H, Chen J, Chen J, Chen J, Chen S, Chen SJ, Chen X, Chen Y, Chen YH, Cheng HC, Cheng HJ, Cheplakov A, Cheremushkina E, Cherkaoui El Moursli R, Cheu E, Cheung K, Chevalérias TJA, Chevalier L, Chiarella V, Chiarelli G, Chiodini G, Chisholm AS, Chitan A, Chiu I, Chiu YH, Chizhov MV, Choi K, Chomont AR, Chou Y, Chow YS, Christopher LD, Chu MC, Chu X, Chudoba J, Chwastowski JJ, Chytka L, Cieri D, Ciesla KM, Cindro V, Cioară IA, Ciocio A, Cirotto F, Citron ZH, Citterio M, Ciubotaru DA, Ciungu BM, Clark A, Clark PJ, Clawson SE, Clement C, Coadou Y, Cobal M, Coccaro A, Cochran J, Coelho Lopes De Sa R, Cohen H, Coimbra AEC, Cole B, Colijn AP, Collot J, Conde Muiño P, Connell SH, Connelly IA, Constantinescu S, Conventi F, Cooper-Sarkar AM, Cormier F, Cormier KJR, Corpe LD, Corradi M, Corrigan EE, Corriveau F, Costa MJ, Costanza F, Costanzo D, Cowan G, Cowley JW, Crane J, Cranmer K, Creager RA, Crépé-Renaudin S, Crescioli F, Cristinziani M, Croft V, Crosetti G, Cueto A, Cuhadar Donszelmann T, Cui H, Cukierman AR, Cunningham WR, Czekierda S, Czodrowski P, Czurylo MM, Da Cunha Sargedas De Sousa MJ, Da Fonseca Pinto JV, Da Via C, Dabrowski W, Dachs F, Dado T, Dahbi S, Dai T, Dallapiccola C, Dam M, D'amen G, D'Amico V, Damp J, Dandoy JR, Daneri MF, Danninger M, Dao V, Darbo G, Dartsi O, Dattagupta A, Daubney T, D'Auria S, David C, Davidek T, Davis DR, Dawson I, De K, De Asmundis R, De Beurs M, De Castro S, De Groot N, de Jong P, De la Torre H, De Maria A, De Pedis D, De Salvo A, De Sanctis U, De Santis M, De Santo A, De Vivie De Regie JB, Dedovich DV, Deiana AM, Del Peso J, Delabat Diaz Y, Delgove D, Deliot F, Delitzsch CM, Della Pietra M, Della Volpe D, Dell'Acqua A, Dell'Asta L, Delmastro M, Delporte C, Delsart PA, Demers S, Demichev M, Demontigny G, Denisov SP, D'Eramo L, Derendarz D, Derkaoui JE, Derue F, Dervan P, Desch K, Dette K, Deutsch C, Devesa MR, Deviveiros PO, Di Bello FA, Di Ciaccio A, Di Ciaccio L, Di Clemente WK, Di Donato C, Di Girolamo A, Di Gregorio G, Di Luca A, Di Micco B, Di Nardo R, Di Petrillo KF, Di Sipio R, Diaconu C, Dias FA, Dias Do Vale T, Diaz MA, Diaz Capriles FG, Dickinson J, Didenko M, Diehl EB, Dietrich J, Díez Cornell S, Diez Pardos C, Dimitrievska A, Ding W, Dingfelder J, Dittmeier SJ, Dittus F, Djama F, Djobava T, Djuvsland JI, Do Vale MAB, Dobre M, Dodsworth D, Doglioni C, Dolejsi J, Dolezal Z, Donadelli M, Dong B, Donini J, D'onofrio A, D'Onofrio M, Dopke J, Doria A, Dova MT, Doyle AT, Drechsler E, Dreyer E, Dreyer T, Drobac AS, Du D, du Pree TA, Duan Y, Dubinin F, Dubovsky M, Dubreuil A, Duchovni E, Duckeck G, Ducu OA, Duda D, Dudarev A, Dudder AC, Duffield EM, D'uffizi M, Duflot L, Dührssen M, Dülsen C, Dumancic M, Dumitriu AE, Dunford M, Dungs S, Duperrin A, Duran Yildiz H, Düren M, Durglishvili A, Duschinger D, Dutta B, Duvnjak D, Dyckes GI, Dyndal M, Dysch S, Dziedzic BS, Eggleston MG, Eifert T, Eigen G, Einsweiler K, Ekelof T, El Jarrari H, Ellajosyula V, Ellert M, Ellinghaus F, Elliot AA, Ellis N, Elmsheuser J, Elsing M, Emeliyanov D, Emerman A, Enari Y, Epland MB, Erdmann J, Ereditato A, Erland PA, Errenst M, Escalier M, Escobar C, Estrada Pastor O, Etzion E, Evans GE, Evans H, Evans MO, Ezhilov A, Fabbri F, Fabbri L, Fabiani V, Facini G, Fakhrutdinov RM, Falciano S, Falke PJ, Falke S, Faltova J, Fang Y, Fang Y, Fanourakis G, Fanti M, Faraj M, Farbin A, Farilla A, Farina EM, Farooque T, Farrington SM, Farthouat P, Fassi F, Fassnacht P, Fassouliotis D, Faucci Giannelli M, Fawcett WJ, Fayard L, Fedin OL, Fedorko W, Fehr A, Feickert M, Feligioni L, Fell A, Feng C, Feng M, Fenton MJ, Fenyuk AB, Ferguson SW, Ferrando J, Ferrari A, Ferrari P, Ferrari R, Ferreira de Lima DE, Ferrer A, Ferrere D, Ferretti C, Fiedler F, Filipčič A, Filthaut F, Finelli KD, Fiolhais MCN, Fiorini L, Fischer F, Fischer J, Fisher WC, Fitschen T, Fleck I, Fleischmann P, Flick T, Flierl BM, Flores L, Flores Castillo LR, Follega FM, Fomin N, Foo JH, Forcolin GT, Forland BC, Formica A, Förster FA, Forti AC, Fortin E, Foti MG, Fournier D, Fox H, Francavilla P, Francescato S, Franchini M, Franchino S, Francis D, Franco L, Franconi L, Franklin M, Frattari G, Fray AN, Freeman PM, Freund B, Freund WS, Freundlich EM, Frizzell DC, Froidevaux D, Frost JA, Fujimoto M, Fukunaga C, Fullana Torregrosa E, Fusayasu T, Fuster J, Gabrielli A, Gabrielli A, Gadatsch S, Gadow P, Gagliardi G, Gagnon LG, Gallardo GE, Gallas EJ, Gallop BJ, Gamboa Goni R, Gan KK, Ganguly S, Gao J, Gao Y, Gao YS, Garay Walls FM, García C, García Navarro JE, García Pascual JA, Garcia-Argos C, Garcia-Sciveres M, Gardner RW, Garelli N, Gargiulo S, Garner CA, Garonne V, Gasiorowski SJ, Gaspar P, Gaudiello A, Gaudio G, Gauzzi P, Gavrilenko IL, Gavrilyuk A, Gay C, Gaycken G, Gazis EN, Geanta AA, Gee CM, Gee CNP, Geisen J, Geisen M, Gemme C, Genest MH, Geng C, Gentile S, George S, Geralis T, Gerlach LO, Gessinger-Befurt P, Gessner G, Ghasemi Bostanabad M, Ghneimat M, Ghosh A, Ghosh A, Giacobbe B, Giagu S, Giangiacomi N, Giannetti P, Giannini A, Giannini G, Gibson SM, Gignac M, Gil DT, Gilbert BJ, Gillberg D, Gilles G, Gillwald NEK, Gingrich DM, Giordani MP, Giraud PF, Giugliarelli G, Giugni D, Giuli F, Gkaitatzis S, Gkialas I, Gkougkousis EL, Gkountoumis P, Gladilin LK, Glasman C, Glatzer J, Glaysher PCF, Glazov A, Gledhill GR, Gnesi I, Goblirsch-Kolb M, Godin D, Goldfarb S, Golling T, Golubkov D, Gomes A, Goncalves Gama R, Gonçalo R, Gonella G, Gonella L, Gongadze A, Gonnella F, Gonski JL, González de la Hoz S, Gonzalez Fernandez S, Gonzalez Lopez R, Gonzalez Renteria C, Gonzalez Suarez R, Gonzalez-Sevilla S, Gonzalvo Rodriguez GR, Goossens L, Gorasia NA, Gorbounov PA, Gordon HA, Gorini B, Gorini E, Gorišek A, Goshaw AT, Gostkin MI, Gottardo CA, Gouighri M, Goussiou AG, Govender N, Goy C, Grabowska-Bold I, Graham EC, Gramling J, Gramstad E, Grancagnolo S, Grandi M, Gratchev V, Gravila PM, Gravili FG, Gray C, Gray HM, Grefe C, Gregersen K, Gregor IM, Grenier P, Grevtsov K, Grieco C, Grieser NA, Grillo AA, Grimm K, Grinstein S, Grivaz JF, Groh S, Gross E, Grosse-Knetter J, Grout ZJ, Grud C, Grummer A, Grundy JC, Guan L, Guan W, Gubbels C, Guenther J, Guerguichon A, Guerrero Rojas JGR, Guescini F, Guest D, Gugel R, Guida A, Guillemin T, Guindon S, Guo J, Guo W, Guo Y, Guo Z, Gupta R, Gurbuz S, Gustavino G, Guth M, Gutierrez P, Gutschow C, Guyot C, Gwenlan C, Gwilliam CB, Haaland ES, Haas A, Haber C, Hadavand HK, Hadef A, Haleem M, Haley J, Hall JJ, Halladjian G, Hallewell GD, Hamano K, Hamdaoui H, Hamer M, Hamity GN, Han K, Han L, Han L, Han S, Han YF, Hanagaki K, Hance M, Handl DM, Hank MD, Hankache R, Hansen E, Hansen JB, Hansen JD, Hansen MC, Hansen PH, Hanson EC, Hara K, Harenberg T, Harkusha S, Harrison PF, Hartman NM, Hartmann NM, Hasegawa Y, Hasib A, Hassani S, Haug S, Hauser R, Havranek M, Hawkes CM, Hawkings RJ, Hayashida S, Hayden D, Hayes C, Hayes RL, Hays CP, Hays JM, Hayward HS, Haywood SJ, He F, He Y, Heath MP, Hedberg V, Heggelund AL, Hehir ND, Heidegger C, Heidegger KK, Heidorn WD, Heilman J, Heim S, Heim T, Heinemann B, Heinlein JG, Heinrich JJ, Heinrich L, Hejbal J, Helary L, Held A, Hellesund S, Helling CM, Hellman S, Helsens C, Henderson RCW, Henkelmann L, Henriques Correia AM, Herde H, Hernández Jiménez Y, Herr H, Herrmann MG, Herrmann T, Herten G, Hertenberger R, Hervas L, Hesketh GG, Hessey NP, Hibi H, Higashino S, Higón-Rodriguez E, Hildebrand K, Hill JC, Hill KK, Hiller KH, Hillier SJ, Hils M, Hinchliffe I, Hinterkeuser F, Hirose M, Hirose S, Hirschbuehl D, Hiti B, Hladik O, Hobbs J, Hobincu R, Hod N, Hodgkinson MC, Hoecker A, Hohn D, Hohov D, Holm T, Holmes TR, Holzbock M, Hommels LBAH, Hong TM, Honig JC, Hönle A, Hooberman BH, Hopkins WH, Horii Y, Horn P, Horyn LA, Hou S, Hoummada A, Howarth J, Hoya J, Hrabovsky M, Hrivnac J, Hrynevich A, Hryn'ova T, Hsu PJ, Hsu SC, Hu Q, Hu S, Hu YF, Huang DP, Huang X, Huang Y, Huang Y, Hubacek Z, Hubaut F, Huebner M, Huegging F, Huffman TB, Huhtinen M, Hulsken R, Hunter RFH, Huseynov N, Huston J, Huth J, Hyneman R, Hyrych S, Iacobucci G, Iakovidis G, Ibragimov I, Iconomidou-Fayard L, Iengo P, Ignazzi R, Iguchi R, Iizawa T, Ikegami Y, Ikeno M, Ilic N, Iltzsche F, Imam H, Introzzi G, Iodice M, Iordanidou K, Ippolito V, Isacson MF, Ishino M, Islam W, Issever C, Istin S, Iturbe Ponce JM, Iuppa R, Ivina A, Izen JM, Izzo V, Jacka P, Jackson P, Jacobs RM, Jaeger BP, Jain V, Jäkel G, Jakobi KB, Jakobs K, Jakoubek T, Jamieson J, Janas KW, Jansky R, Janus M, Janus PA, Jarlskog G, Jaspan AE, Javadov N, Javůrek T, Javurkova M, Jeanneau F, Jeanty L, Jejelava J, Jenni P, Jeong N, Jézéquel S, Jia J, Jia Z, Jiang H, Jiang Y, Jiang Z, Jiggins S, Jimenez Morales FA, Jimenez Pena J, Jin S, Jinaru A, Jinnouchi O, Jivan H, Johansson P, Johns KA, Johnson CA, Jones E, Jones RWL, Jones SD, Jones TJ, Jovicevic J, Ju X, Junggeburth JJ, Juste Rozas A, Kaczmarska A, Kado M, Kagan H, Kagan M, Kahn A, Kahra C, Kaji T, Kajomovitz E, Kalderon CW, Kaluza A, Kamenshchikov A, Kaneda M, Kang NJ, Kang S, Kano Y, Kanzaki J, Kaplan LS, Kar D, Karava K, Kareem MJ, Karkanias I, Karpov SN, Karpova ZM, Kartvelishvili V, Karyukhin AN, Kasimi E, Kastanas A, Kato C, Katzy J, Kawade K, Kawagoe K, Kawaguchi T, Kawamoto T, Kawamura G, Kay EF, Kaya FI, Kazakos S, Kazanin VF, Keaveney JM, Keeler R, Keller JS, Kellermann E, Kelsey D, Kempster JJ, Kendrick J, Kennedy KE, Kepka O, Kersten S, Kerševan BP, Ketabchi Haghighat S, Khalil-Zada F, Khandoga M, Khanov A, Kharlamov AG, Kharlamova T, Khoda EE, Khoo TJ, Khoriauli G, Khramov E, Khubua J, Kido S, Kiehn M, Kim E, Kim YK, Kimura N, Kirchhoff A, Kirchmeier D, Kirk J, Kiryunin AE, Kishimoto T, Kisliuk DP, Kitali V, Kitsaki C, Kivernyk O, Klapdor-Kleingrothaus T, Klassen M, Klein C, Klein MH, Klein M, Klein U, Kleinknecht K, Klimek P, Klimentov A, Klimpel F, Klingl T, Klioutchnikova T, Klitzner FF, Kluit P, Kluth S, Kneringer E, Knoops EBFG, Knue A, Kobayashi D, Kobel M, Kocian M, Kodama T, Kodys P, Koeck DM, Koenig PT, Koffas T, Köhler NM, Kolb M, Koletsou I, Komarek T, Kondo T, Köneke K, Kong AXY, König AC, Kono T, Konstantinides V, Konstantinidis N, Konya B, Kopeliansky R, Koperny S, Korcyl K, Kordas K, Koren G, Korn A, Korolkov I, Korolkova EV, Korotkova N, Kortner O, Kortner S, Kostyukhin VV, Kotsokechagia A, Kotwal A, Koulouris A, Kourkoumeli-Charalampidi A, Kourkoumelis C, Kourlitis E, Kouskoura V, Kowalewski R, Kozanecki W, Kozhin AS, Kramarenko VA, Kramberger G, Krasnopevtsev D, Krasny MW, Krasznahorkay A, Krauss D, Kremer JA, Kretzschmar J, Kreul K, Krieger P, Krieter F, Krishnamurthy S, Krishnan A, Krivos M, Krizka K, Kroeninger K, Kroha H, Kroll J, Kroll J, Krowpman KS, Kruchonak U, Krüger H, Krumnack N, Kruse MC, Krzysiak JA, Kubota A, Kuchinskaia O, Kuday S, Kuechler D, Kuechler JT, Kuehn S, Kuhl T, Kukhtin V, Kulchitsky Y, Kuleshov S, Kulinich YP, Kuna M, Kupco A, Kupfer T, Kuprash O, Kurashige H, Kurchaninov LL, Kurochkin YA, Kurova A, Kurth MG, Kuwertz ES, Kuze M, Kvam AK, Kvita J, Kwan T, Lacasta C, Lacava F, Lack DPJ, Lacker H, Lacour D, Ladygin E, Lafaye R, Laforge B, Lagouri T, Lai S, Lakomiec IK, Lambert JE, Lammers S, Lampl W, Lampoudis C, Lançon E, Landgraf U, Landon MPJ, Lang VS, Lange JC, Langenberg RJ, Lankford AJ, Lanni F, Lantzsch K, Lanza A, Lapertosa A, Laporte JF, Lari T, Lasagni Manghi F, Lassnig M, Latonova V, Lau TS, Laudrain A, Laurier A, Lavorgna M, Lawlor SD, Lazzaroni M, Le B, Le Guirriec E, Lebedev A, LeBlanc M, LeCompte T, Ledroit-Guillon F, Lee ACA, Lee CA, Lee GR, Lee L, Lee SC, Lee S, Lefebvre B, Lefebvre HP, Lefebvre M, Leggett C, Lehmann K, Lehmann N, Lehmann Miotto G, Leight WA, Leisos A, Leite MAL, Leitgeb CE, Leitner R, Leney KJC, Lenz T, Leone S, Leonidopoulos C, Leopold A, Leroy C, Les R, Lester CG, Levchenko M, Levêque J, Levin D, Levinson LJ, Lewis DJ, Li B, Li B, Li CQ, Li F, Li H, Li H, Li J, Li K, Li L, Li M, Li QY, Li S, Li X, Li Y, Li Z, Li Z, Li Z, Li Z, Liang Z, Liberatore M, Liberti B, Lie K, Lim S, Lin CY, Lin K, Linck RA, Lindley RE, Lindon JH, Linss A, Lionti AL, Lipeles E, Lipniacka A, Liss TM, Lister A, Little JD, Liu B, Liu BL, Liu HB, Liu JB, Liu JKK, Liu K, Liu M, Liu MY, Liu P, Liu X, Liu Y, Liu Y, Liu YL, Liu YW, Livan M, Lleres A, Llorente Merino J, Lloyd SL, Lo CY, Lobodzinska EM, Loch P, Loffredo S, Lohse T, Lohwasser K, Lokajicek M, Long JD, Long RE, Longarini I, Longo L, Lopez Paz I, Lopez Solis A, Lorenz J, Lorenzo Martinez N, Lory AM, Lösle A, Lou X, Lou X, Lounis A, Love J, Love PA, Lozano Bahilo JJ, Lu M, Lu YJ, Lubatti HJ, Luci C, Lucio Alves FL, Lucotte A, Luehring F, Luise I, Luminari L, Lund-Jensen B, Luongo NA, Lutz MS, Lynn D, Lyons H, Lysak R, Lytken E, Lyu F, Lyubushkin V, Lyubushkina T, Ma H, Ma LL, Ma Y, Mac Donell DM, Maccarrone G, Macdonald CM, MacDonald JC, Machado Miguens J, Madar R, Mader WF, Madugoda Ralalage Don M, Madysa N, Maeda J, Maeno T, Maerker M, Magerl V, Magini N, Magro J, Mahon DJ, Maidantchik C, Maio A, Maj K, Majersky O, Majewski S, Makida Y, Makovec N, Malaescu B, Malecki P, Maleev VP, Malek F, Malito D, Mallik U, Malone C, Maltezos S, Malyukov S, Mamuzic J, Mancini G, Mandalia JP, Mandić I, Manhaes de Andrade Filho L, Maniatis IM, Manjarres Ramos J, Mankinen KH, Mann A, Manousos A, Mansoulie B, Manthos I, Manzoni S, Marantis A, Marceca G, Marchese L, Marchiori G, Marcisovsky M, Marcoccia L, Marcon C, Marjanovic M, Marshall Z, Martensson MUF, Marti-Garcia S, Martin CB, Martin TA, Martin VJ, Martin Dit Latour B, Martinelli L, Martinez M, Martinez Agullo P, Martinez Outschoorn VI, Martin-Haugh S, Martoiu VS, Martyniuk AC, Marzin A, Maschek SR, Masetti L, Mashimo T, Mashinistov R, Masik J, Maslennikov AL, Massa L, Massarotti P, Mastrandrea P, Mastroberardino A, Masubuchi T, Matakias D, Matic A, Matsuzawa N, Mättig P, Maurer J, Maček B, Maximov DA, Mazini R, Maznas I, Mazza SM, Mc Gowan JP, Mc Kee SP, McCarthy TG, McCormack WP, McDonald EF, McDougall AE, Mcfayden JA, Mchedlidze G, McKay MA, McLean KD, McMahon SJ, McNamara PC, McNicol CJ, McPherson RA, Mdhluli JE, Meadows ZA, Meehan S, Megy T, Mehlhase S, Mehta A, Meirose B, Melini D, Mellado Garcia BR, Mellenthin JD, Melo M, Meloni F, Melzer A, Mendes Gouveia ED, Mendes Jacques Da Costa AM, Meng HY, Meng L, Meng XT, Menke S, Meoni E, Mergelmeyer S, Merkt SAM, Merlassino C, Mermod P, Merola L, Meroni C, Merz G, Meshkov O, Meshreki JKR, Metcalfe J, Mete AS, Meyer C, Meyer JP, Michetti M, Middleton RP, Mijović L, Mikenberg G, Mikestikova M, Mikuž M, Mildner H, Milic A, Milke CD, Miller DW, Miller LS, Milov A, Milstead DA, Minaenko AA, Minashvili IA, Mince L, Mincer AI, Mindur B, Mineev M, Minegishi Y, Mino Y, Mir LM, Mironova M, Mitani T, Mitrevski J, Mitsou VA, Mittal M, Miu O, Miucci A, Miyagawa PS, Mizukami A, Mjörnmark JU, Mkrtchyan T, Mlynarikova M, Moa T, Mobius S, Mochizuki K, Moder P, Mogg P, Mohapatra S, Moles-Valls R, Mönig K, Monnier E, Montalbano A, Montejo Berlingen J, Montella M, Monticelli F, Monzani S, Morange N, Moreira De Carvalho AL, Moreno D, Moreno Llácer M, Moreno Martinez C, Morettini P, Morgenstern M, Morgenstern S, Mori D, Morii M, Morinaga M, Morisbak V, Morley AK, Mornacchi G, Morris AP, Morvaj L, Moschovakos P, Moser B, Mosidze M, Moskalets T, Moskvitina P, Moss J, Moyse EJW, Muanza S, Mueller J, Mueller RSP, Muenstermann D, Mullier GA, Mungo DP, Munoz Martinez JL, Munoz Sanchez FJ, Murin P, Murray WJ, Murrone A, Muse JM, Muškinja M, Mwewa C, Myagkov AG, Myers AA, Myers G, Myers J, Myska M, Nachman BP, Nackenhorst O, Nag AN, Nagai K, Nagano K, Nagasaka Y, Nagle JL, Nagy E, Nairz AM, Nakahama Y, Nakamura K, Nakamura T, Nanjo H, Napolitano F, Naranjo Garcia RF, Narayan R, Naryshkin I, Naseri M, Naumann T, Navarro G, Nechaeva PY, Nechansky F, Neep TJ, Negri A, Negrini M, Nellist C, Nelson C, Nelson ME, Nemecek S, Nessi M, Neubauer MS, Neuhaus F, Neumann M, Newhouse R, Newman PR, Ng CW, Ng YS, Ng YWY, Ngair B, Nguyen HDN, Nguyen Manh T, Nibigira E, Nickerson RB, Nicolaidou R, Nielsen DS, Nielsen J, Niemeyer M, Nikiforou N, Nikolaenko V, Nikolic-Audit I, Nikolopoulos K, Nilsson P, Nindhito HR, Nisati A, Nishu N, Nisius R, Nitsche I, Nitta T, Nobe T, Noel DL, Noguchi Y, Nomidis I, Nomura MA, Nordberg M, Novak J, Novak T, Novgorodova O, Novotny R, Nozka L, Ntekas K, Nurse E, Oakham FG, Ocariz J, Ochi A, Ochoa I, Ochoa-Ricoux JP, O'Connor K, Oda S, Odaka S, Oerdek S, Ogrodnik A, Oh A, Ohm CC, Oide H, Oishi R, Ojeda ML, Okawa H, Okazaki Y, O'Keefe MW, Okumura Y, Olariu A, Oleiro Seabra LF, Olivares Pino SA, Oliveira Damazio D, Oliver JL, Olsson MJR, Olszewski A, Olszowska J, Öncel ÖO, O'Neil DC, O'neill AP, Onofre A, Onyisi PUE, Oppen H, Oreamuno Madriz RG, Oreglia MJ, Orellana GE, Orestano D, Orlando N, Orr RS, O'Shea V, Ospanov R, Otero Y Garzon G, Otono H, Ott PS, Ottino GJ, Ouchrif M, Ouellette J, Ould-Saada F, Ouraou A, Ouyang Q, Owen M, Owen RE, Ozcan VE, Ozturk N, Pacalt J, Pacey HA, Pachal K, Pacheco Pages A, Padilla Aranda C, Pagan Griso S, Palacino G, Palazzo S, Palestini S, Palka M, Palni P, Pandini CE, Panduro Vazquez JG, Pani P, Panizzo G, Paolozzi L, Papadatos C, Papageorgiou K, Parajuli S, Paramonov A, Paraskevopoulos C, Paredes Hernandez D, Paredes Saenz SR, Parida B, Park TH, Parker AJ, Parker MA, Parodi F, Parrish EW, Parsons JA, Parzefall U, Pascual Dominguez L, Pascuzzi VR, Pasner JMP, Pasquali F, Pasqualucci E, Passaggio S, Pastore F, Pasuwan P, Pataraia S, Pater JR, Pathak A, Patton J, Pauly T, Pearkes J, Pedersen M, Pedraza Diaz L, Pedro R, Peiffer T, Peleganchuk SV, Penc O, Peng C, Peng H, Peralva BS, Perego MM, Pereira Peixoto AP, Pereira Sanchez L, Perepelitsa DV, Perez Codina E, Perini L, Pernegger H, Perrella S, Perrevoort A, Peters K, Peters RFY, Petersen BA, Petersen TC, Petit E, Petousis V, Petridou C, Petrucci F, Pettee M, Pettersson NE, Petukhova K, Peyaud A, Pezoa R, Pezzotti L, Pham T, Phillips PW, Phipps MW, Piacquadio G, Pianori E, Picazio A, Pickles RH, Piegaia R, Pietreanu D, Pilcher JE, Pilkington AD, Pinamonti M, Pinfold JL, Pitman Donaldson C, Pitt M, Pizzimento L, Pizzini A, Pleier MA, Plesanovs V, Pleskot V, Plotnikova E, Podberezko P, Poettgen R, Poggi R, Poggioli L, Pogrebnyak I, Pohl D, Pokharel I, Polesello G, Poley A, Policicchio A, Polifka R, Polini A, Pollard CS, Polychronakos V, Ponomarenko D, Pontecorvo L, Popa S, Popeneciu GA, Portales L, Portillo Quintero DM, Pospisil S, Potamianos K, Potrap IN, Potter CJ, Potti H, Poulsen T, Poveda J, Powell TD, Pownall G, Pozo Astigarraga ME, Prades Ibanez A, Pralavorio P, Prapa MM, Prell S, Price D, Primavera M, Proffitt ML, Proklova N, Prokofiev K, Prokoshin F, Protopopescu S, Proudfoot J, Przybycien M, Pudzha D, Puri A, Puzo P, Pyatiizbyantseva D, Qian J, Qin Y, Quadt A, Queitsch-Maitland M, Rabanal Bolanos G, Racko M, Ragusa F, Rahal G, Raine JA, Rajagopalan S, Ramirez Morales A, Ran K, Rassloff DF, Rauch DM, Rauscher F, Rave S, Ravina B, Ravinovich I, Rawling JH, Raymond M, Read AL, Readioff NP, Reale M, Rebuzzi DM, Redlinger G, Reeves K, Reikher D, Reiss A, Rej A, Rembser C, Renardi A, Renda M, Rendel MB, Rennie AG, Resconi S, Resseguie ED, Rettie S, Reynolds B, Reynolds E, Rezanova OL, Reznicek P, Ricci E, Richter R, Richter S, Richter-Was E, Ridel M, Rieck P, Rifki O, Rijssenbeek M, Rimoldi A, Rimoldi M, Rinaldi L, Rinn TT, Ripellino G, Riu I, Rivadeneira P, Rivera Vergara JC, Rizatdinova F, Rizvi E, Rizzi C, Robertson SH, Robin M, Robinson D, Robles Gajardo CM, Robles Manzano M, Robson A, Rocchi A, Roda C, Rodriguez Bosca S, Rodriguez Rodriguez A, Rodríguez Vera AM, Roe S, Roggel J, Røhne O, Röhrig R, Rojas RA, Roland B, Roland CPA, Roloff J, Romaniouk A, Romano M, Rompotis N, Ronzani M, Roos L, Rosati S, Rosin G, Rosser BJ, Rossi E, Rossi E, Rossi E, Rossi LP, Rossini L, Rosten R, Rotaru M, Rottler B, Rousseau D, Rovelli G, Roy A, Roy D, Rozanov A, Rozen Y, Ruan X, Ruggeri TA, Rühr F, Ruiz-Martinez A, Rummler A, Rurikova Z, Rusakovich NA, Russell HL, Rustige L, Rutherfoord JP, Rüttinger EM, Rybar M, Rybkin G, Rye EB, Ryzhov A, Sabater Iglesias JA, Sabatini P, Sabetta L, Sacerdoti S, Sadrozinski HFW, Sadykov R, Safai Tehrani F, Safarzadeh Samani B, Safdari M, Saha P, Saha S, Sahinsoy M, Sahu A, Saimpert M, Saito M, Saito T, Sakamoto H, Salamani D, Salamanna G, Salnikov A, Salt J, Salvador Salas A, Salvatore D, Salvatore F, Salvucci A, Salzburger A, Samarati J, Sammel D, Sampsonidis D, Sampsonidou D, Sánchez J, Sanchez Pineda A, Sandaker H, Sander CO, Sanderswood IG, Sandhoff M, Sandoval C, Sankey DPC, Sannino M, Sano Y, Sansoni A, Santoni C, Santos H, Santpur SN, Santra A, Saoucha KA, Sapronov A, Saraiva JG, Sasaki O, Sato K, Sauerburger F, Sauvan E, Savard P, Sawada R, Sawyer C, Sawyer L, Sayago Galvan I, Sbarra C, Sbrizzi A, Scanlon T, Schaarschmidt J, Schacht P, Schaefer D, Schaefer L, Schäfer U, Schaffer AC, Schaile D, Schamberger RD, Schanet E, Scharf C, Scharmberg N, Schegelsky VA, Scheirich D, Schenck F, Schernau M, Schiavi C, Schildgen LK, Schillaci ZM, Schioppa EJ, Schioppa M, Schleicher KE, Schlenker S, Schmidt-Sommerfeld KR, Schmieden K, Schmitt C, Schmitt S, Schoeffel L, Schoening A, Scholer PG, Schopf E, Schott M, Schouwenberg JFP, Schovancova J, Schramm S, Schroeder F, Schulte A, Schultz-Coulon HC, Schumacher M, Schumm BA, Schune P, Schwartzman A, Schwarz TA, Schwemling P, Schwienhorst R, Sciandra A, Sciolla G, Scuri F, Scutti F, Scyboz LM, Sebastiani CD, Sedlaczek K, Seema P, Seidel SC, Seiden A, Seidlitz BD, Seiss T, Seitz C, Seixas JM, Sekhniaidze G, Sekula SJ, Semprini-Cesari N, Sen S, Serfon C, Serin L, Serkin L, Sessa M, Severini H, Sevova S, Sforza F, Sfyrla A, Shabalina E, Shahinian JD, Shaikh NW, Shaked Renous D, Shan LY, Shapiro M, Sharma A, Sharma AS, Shatalov PB, Shaw K, Shaw SM, Shehade M, Shen Y, Sherman AD, Sherwood P, Shi L, Shimmin CO, Shimogama Y, Shimojima M, Shinner JD, Shipsey IPJ, Shirabe S, Shiyakova M, Shlomi J, Shmeleva A, Shochet MJ, Shojaii J, Shope DR, Shrestha S, Shrif EM, Shroff MJ, Shulga E, Sicho P, Sickles AM, Sideras Haddad E, Sidiropoulou O, Sidoti A, Siegert F, Sijacki D, Silva M, Silva Oliveira MV, Silverstein SB, Simion S, Simoniello R, Simpson-Allsop CJ, Simsek S, Sinervo P, Sinetckii V, Singh S, Sinha S, Sioli M, Siral I, Sivoklokov SY, Sjölin J, Skaf A, Skorda E, Skubic P, Slawinska M, Sliwa K, Smakhtin V, Smart BH, Smiesko J, Smirnov N, Smirnov SY, Smirnov Y, Smirnova LN, Smirnova O, Smith EA, Smith HA, Smizanska M, Smolek K, Smykiewicz A, Snesarev AA, Snoek HL, Snyder IM, Snyder S, Sobie R, Soffer A, Søgaard A, Sohns F, Solans Sanchez CA, Soldatov EY, Soldevila U, Solodkov AA, Soloshenko A, Solovyanov OV, Solovyev V, Sommer P, Son H, Sonay A, Song W, Song WY, Sopczak A, Sopio AL, Sopkova F, Sottocornola S, Soualah R, Soukharev AM, South D, Spagnolo S, Spalla M, Spangenberg M, Spanò F, Sperlich D, Spieker TM, Spigo G, Spina M, Spiteri DP, Spousta M, Stabile A, Stamas BL, Stamen R, Stamenkovic M, Stampekis A, Stanecka E, Stanislaus B, Stanitzki MM, Stankaityte M, Stapf B, Starchenko EA, Stark GH, Stark J, Staroba P, Starovoitov P, Stärz S, Staszewski R, Stavropoulos G, Stegler M, Steinberg P, Steinhebel AL, Stelzer B, Stelzer HJ, Stelzer-Chilton O, Stenzel H, Stevenson TJ, Stewart GA, Stockton MC, Stoicea G, Stolarski M, Stonjek S, Straessner A, Strandberg J, Strandberg S, Strauss M, Strebler T, Strizenec P, Ströhmer R, Strom DM, Stroynowski R, Strubig A, Stucci SA, Stugu B, Stupak J, Styles NA, Su D, Su W, Su X, Suarez NB, Sulin VV, Sullivan MJ, Sultan DMS, Sultansoy S, Sumida T, Sun S, Sun X, Suster CJE, Sutton MR, Suzuki S, Svatos M, Swiatlowski M, Swift SP, Swirski T, Sydorenko A, Sykora I, Sykora M, Sykora T, Ta D, Tackmann K, Taenzer J, Taffard A, Tafirout R, Tagiev E, Taibah RHM, Takashima R, Takeda K, Takeshita T, Takeva EP, Takubo Y, Talby M, Talyshev AA, Tam KC, Tamir NM, Tanaka J, Tanaka R, Tapia Araya S, Tapprogge S, Tarek Abouelfadl Mohamed A, Tarem S, Tariq K, Tarna G, Tartarelli GF, Tas P, Tasevsky M, Tassi E, Tateno G, Tavares Delgado A, Tayalati Y, Taylor AJ, Taylor GN, Taylor W, Teagle H, Tee AS, Teixeira De Lima R, Teixeira-Dias P, Ten Kate H, Teoh JJ, Terashi K, Terron J, Terzo S, Testa M, Teuscher RJ, Themistokleous N, Theveneaux-Pelzer T, Thomas DW, Thomas JP, Thompson EA, Thompson PD, Thomson E, Thorpe EJ, Tikhomirov VO, Tikhonov YA, Timoshenko S, Tipton P, Tisserant S, Todome K, Todorova-Nova S, Todt S, Tojo J, Tokár S, Tokushuku K, Tolley E, Tombs R, Tomiwa KG, Tomoto M, Tompkins L, Tornambe P, Torrence E, Torres H, Torró Pastor E, Toscani M, Tosciri C, Toth J, Tovey DR, Traeet A, Treado CJ, Trefzger T, Tresoldi F, Tricoli A, Trigger IM, Trincaz-Duvoid S, Trischuk DA, Trischuk W, Trocmé B, Trofymov A, Troncon C, Trovato F, Truong L, Trzebinski M, Trzupek A, Tsai F, Tsiareshka PV, Tsirigotis A, Tsiskaridze V, Tskhadadze EG, Tsopoulou M, Tsukerman II, Tsulaia V, Tsuno S, Tsybychev D, Tu Y, Tudorache A, Tudorache V, Tuna AN, Turchikhin S, Turgeman D, Turk Cakir I, Turner RJ, Turra R, Tuts PM, Tzamarias S, Tzovara E, Uchida K, Ukegawa F, Unal G, Unal M, Undrus A, Unel G, Ungaro FC, Unno Y, Uno K, Urban J, Urquijo P, Usai G, Uysal Z, Vacek V, Vachon B, Vadla KOH, Vafeiadis T, Vaidya A, Valderanis C, Valdes Santurio E, Valente M, Valentinetti S, Valero A, Valéry L, Vallance RA, Vallier A, Valls Ferrer JA, Van Daalen TR, Van Gemmeren P, Van Stroud S, Van Vulpen I, Vanadia M, Vandelli W, Vandenbroucke M, Vandewall ER, Vannicola D, Vari R, Varnes EW, Varni C, Varol T, Varouchas D, Varvell KE, Vasile ME, Vasquez GA, Vazeille F, Vazquez Furelos D, Vazquez Schroeder T, Veatch J, Vecchio V, Veen MJ, Veloce LM, Veloso F, Veneziano S, Ventura A, Verbytskyi A, Vercesi V, Verducci M, Vergel Infante CM, Vergis C, Verkerke W, Vermeulen AT, Vermeulen JC, Vernieri C, Verschuuren PJ, Vetterli MC, Viaux Maira N, Vickey T, Vickey Boeriu OE, Viehhauser GHA, Vigani L, Villa M, Villaplana Perez M, Villhauer EM, Vilucchi E, Vincter MG, Virdee GS, Vishwakarma A, Vittori C, Vivarelli I, Vogel M, Vokac P, Von Ahnen J, von Buddenbrock SE, Von Toerne E, Vorobel V, Vorobev K, Vos M, Vossebeld JH, Vozak M, Vranjes N, Vranjes Milosavljevic M, Vrba V, Vreeswijk M, Vu NK, Vuillermet R, Vukotic I, Wada S, Wagner P, Wagner W, Wagner-Kuhr J, Wahdan S, Wahlberg H, Wakasa R, Walbrecht VM, Walder J, Walker R, Walker SD, Walkowiak W, Wallangen V, Wang AM, Wang AZ, Wang C, Wang C, Wang H, Wang H, Wang J, Wang P, Wang Q, Wang RJ, Wang R, Wang R, Wang SM, Wang WT, Wang W, Wang WX, Wang Y, Wang Z, Wanotayaroj C, Warburton A, Ward CP, Ward RJ, Warrack N, Watson AT, Watson MF, Watts G, Waugh BM, Webb AF, Weber C, Weber MS, Weber SA, Weber SM, Wei Y, Weidberg AR, Weingarten J, Weirich M, Weiser C, Wells PS, Wenaus T, Wendland B, Wengler T, Wenig S, Wermes N, Wessels M, Weston TD, Whalen K, Wharton AM, White AS, White A, White MJ, Whiteson D, Whitmore BW, Wiedenmann W, Wiel C, Wielers M, Wieseotte N, Wiglesworth C, Wiik-Fuchs LAM, Wilkens HG, Wilkins LJ, Williams DM, Williams HH, Williams S, Willocq S, Windischhofer PJ, Wingerter-Seez I, Winkels E, Winklmeier F, Winter BT, Wittgen M, Wobisch M, Wolf A, Wölker R, Wollrath J, Wolter MW, Wolters H, Wong VWS, Wongel AF, Woods NL, Worm SD, Wosiek BK, Woźniak KW, Wraight K, Wu SL, Wu X, Wu Y, Wuerzinger J, Wyatt TR, Wynne BM, Xella S, Xia L, Xiang J, Xiao X, Xie X, Xiotidis I, Xu D, Xu H, Xu H, Xu L, Xu R, Xu T, Xu W, Xu Y, Xu Z, Xu Z, Yabsley B, Yacoob S, Yallup DP, Yamaguchi N, Yamaguchi Y, Yamamoto A, Yamatani M, Yamazaki T, Yamazaki Y, Yan J, Yan Z, Yang HJ, Yang HT, Yang S, Yang T, Yang X, Yang X, Yang Y, Yang Z, Yao WM, Yap YC, Ye H, Ye J, Ye S, Yeletskikh I, Yexley MR, Yigitbasi E, Yin P, Yorita K, Yoshihara K, Young CJS, Young C, Yu J, Yuan R, Yue X, Zaazoua M, Zabinski B, Zacharis G, Zaffaroni E, Zahreddine J, Zaitsev AM, Zakareishvili T, Zakharchuk N, Zambito S, Zanzi D, Zeißner SV, Zeitnitz C, Zemaityte G, Zeng JC, Zenin O, Ženiš T, Zerwas D, Zgubič M, Zhang B, Zhang DF, Zhang G, Zhang J, Zhang K, Zhang L, Zhang L, Zhang M, Zhang R, Zhang S, Zhang X, Zhang X, Zhang Y, Zhang Z, Zhang Z, Zhao P, Zhao Y, Zhao Z, Zhemchugov A, Zheng Z, Zhong D, Zhou B, Zhou C, Zhou H, Zhou M, Zhou N, Zhou Y, Zhu CG, Zhu C, Zhu HL, Zhu H, Zhu J, Zhu Y, Zhuang X, Zhukov K, Zhulanov V, Zieminska D, Zimine NI, Zimmermann S, Zinonos Z, Ziolkowski M, Živković L, Zobernig G, Zoccoli A, Zoch K, Zorbas TG, Zou R, Zwalinski L. Search for Dark Matter Produced in Association with a Dark Higgs Boson Decaying into W^{±}W^{∓} or ZZ in Fully Hadronic Final States from sqrt[s]=13 TeV pp Collisions Recorded with the ATLAS Detector. PHYSICAL REVIEW LETTERS 2021; 126:121802. [PMID: 33834820 DOI: 10.1103/physrevlett.126.121802] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/15/2020] [Accepted: 01/19/2021] [Indexed: 06/12/2023]
Abstract
Several extensions of the Standard Model predict the production of dark matter particles at the LHC. An uncharted signature of dark matter particles produced in association with VV=W^{±}W^{∓} or ZZ pairs from a decay of a dark Higgs boson s is searched for using 139 fb^{-1} of pp collisions recorded by the ATLAS detector at a center-of-mass energy of 13 TeV. The s→V(qq[over ¯])V(qq[over ¯]) decays are reconstructed with a novel technique aimed at resolving the dense topology from boosted VV pairs using jets in the calorimeter and tracking information. Dark Higgs scenarios with m_{s}>160 GeV are excluded.
Collapse
|
121
|
Guo R, Lü M, Cao F, Wu G, Gao F, Pang H, Li Y, Zhang Y, Xing H, Liang C, Lyu T, Du C, Li Y, Guo R, Xie X, Li W, Liu D, Song Y, Jiang Z. Single-cell map of diverse immune phenotypes in the acute myeloid leukemia microenvironment. Biomark Res 2021; 9:15. [PMID: 33648605 PMCID: PMC7919996 DOI: 10.1186/s40364-021-00265-0] [Citation(s) in RCA: 41] [Impact Index Per Article: 13.7] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2020] [Accepted: 02/04/2021] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND Knowledge of immune cell phenotypes, function, and developmental trajectory in acute myeloid leukemia (AML) microenvironment is essential for understanding mechanisms of evading immune surveillance and immunotherapy response of targeting special microenvironment components. METHODS Using a single-cell RNA sequencing (scRNA-seq) dataset, we analyzed the immune cell phenotypes, function, and developmental trajectory of bone marrow (BM) samples from 16 AML patients and 4 healthy donors, but not AML blasts. RESULTS We observed a significant difference between normal and AML BM immune cells. Here, we defined the diversity of dendritic cells (DC) and macrophages in different AML patients. We also identified several unique immune cell types including T helper cell 17 (TH17)-like intermediate population, cytotoxic CD4+ T subset, T cell: erythrocyte complexes, activated regulatory T cells (Treg), and CD8+ memory-like subset. Emerging AML cells remodels the BM immune microenvironment powerfully, leads to immunosuppression by accumulating exhausted/dysfunctional immune effectors, expending immune-activated types, and promoting the formation of suppressive subsets. CONCLUSION Our results provide a comprehensive AML BM immune cell census, which can help to select pinpoint targeted drug and predict efficacy of immunotherapy.
Collapse
|
122
|
Wen J, Shao P, Chen Y, Wang L, Lv X, Yang W, Jia Y, Jiang Z, Zhu B, Qu L. Genomic scan revealed KIT gene underlying white/gray plumage color in Chinese domestic geese. Anim Genet 2021; 52:356-360. [PMID: 33644907 DOI: 10.1111/age.13050] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/01/2021] [Indexed: 01/17/2023]
Abstract
Goose is an important type of domesticated poultry. The wild geese that are regarded as the ancestors of modern domestic geese present gray plumage. Domesticated, geese have both white and gray feathers. To elucidate the genetic mechanisms underlying the formation of white and gray plumage in geese, we resequenced the whole genome of 18 geese from six populations including white and gray goose breeds. The average sequencing depth per individual was 9.81× and the average genome coverage was 96.8%. A total of 346 genes were detected in the top 1% of FST scores of gray- and white-feathered geese, and a significant FST site was located in the intron region within the KIT gene, the 18 bp deletion in KIT having the strongest potential association with white feathers. It has been reported that a number of genes are associated with plumage colors in birds. However, no studies have identified the relationship between KIT and plumage color in birds at present, although the white coat can be attributed to mutations in KIT in some mammals. Our study showed that that KIT is a plausible candidate gene for white/gray plumage color in Chinese domestic geese.
Collapse
|
123
|
Mei H, Liu X, Li Y, Zhou H, Feng Y, Gao G, Cheng P, Huang R, Yang L, Hu J, Hou M, Yao Y, Liu L, Wang Y, Wu D, Zhang L, Zheng C, Shen X, Hu Q, Liu J, Jin J, Luo J, Zeng Y, Gao S, Zhang X, Zhou X, Shi Q, Xia R, Xie X, Jiang Z, Gao L, Bai Y, Li Y, Xiong J, Li R, Zou J, Niu T, Yang R, Hu Y. A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia. J Hematol Oncol 2021; 14:37. [PMID: 33632264 PMCID: PMC7905908 DOI: 10.1186/s13045-021-01047-9] [Citation(s) in RCA: 31] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2020] [Accepted: 02/10/2021] [Indexed: 02/08/2023] Open
Abstract
Background Hetrombopag, a novel thrombopoietin receptor agonist, has been found in phase I studies to increase platelet counts and reduce bleeding risks in adults with immune thrombocytopenia (ITP). This phase III study aimed to evaluate the efficacy and safety of hetrombopag in ITP patients. Methods Patients who had not responded to or had relapsed after previous treatment were treated with an initial dosage of once-daily 2.5 or 5 mg hetrombopag (defined as the HETROM-2.5 or HETROM-5 group) or with matching placebo in a randomized, double-blind, 10-week treatment period. Patients who received placebo and completed 10 weeks of treatment switched to receive eltrombopag, and patients treated with hetrombopag in the double-blind period continued hetrombopag during the following open-label 14-week treatment. The primary endpoint was the proportion of responders (defined as those achieving a platelet count of ≥ 50 × 109/L) after 8 weeks of treatment. Results The primary endpoint was achieved by significantly more patients in the HETROM-2.5 (58.9%; odds ratio [OR] 25.97, 95% confidence interval [CI] 9.83–68.63; p < 0.0001) and HETROM-5 (64.3%; OR 32.81, 95% CI 12.39–86.87; p < 0.0001) group than in the Placebo group (5.9%). Hetrombopag was also superior to placebo in achieving a platelet response and in reducing the bleeding risk and use of rescue therapy throughout 8 weeks of treatment. The durable platelet response to hetrombopag was maintained throughout 24 weeks. The most common adverse events were upper respiratory tract infection (42.2%), urinary tract infection (17.1%), immune thrombocytopenic purpura (17.1%) and hematuria (15%) with 24-week hetrombopag treatment. Conclusions In ITP patients, hetrombopag is efficacious and well tolerated with a manageable safety profile.
Trial registration Clinical trials.gov NCT03222843, registered July 19, 2017, retrospectively registered.
Collapse
|
124
|
Aad G, Abbott B, Abbott DC, Abed Abud A, Abeling K, Abhayasinghe DK, Abidi SH, AbouZeid OS, Abraham NL, Abramowicz H, Abreu H, Abulaiti Y, Acharya BS, Achkar B, Adam L, Adam Bourdarios C, Adamczyk L, Adamek L, Adelman J, Adersberger M, Adiguzel A, Adorni S, Adye T, Affolder AA, Afik Y, Agapopoulou C, Agaras MN, Aggarwal A, Agheorghiesei C, Aguilar-Saavedra JA, Ahmad A, Ahmadov F, Ahmed WS, Ai X, Aielli G, Akatsuka S, Akbiyik M, Åkesson TPA, Akilli E, Akimov AV, Al Khoury K, Alberghi GL, Albert J, Alconada Verzini MJ, Alderweireldt S, Aleksa M, Aleksandrov IN, Alexa C, Alexopoulos T, Alfonsi A, Alfonsi F, Alhroob M, Ali B, Ali S, Aliev M, Alimonti G, Allaire C, Allbrooke BMM, Allen BW, Allport PP, Aloisio A, Alonso F, Alpigiani C, Alunno Camelia E, Alvarez Estevez M, Alviggi MG, Amaral Coutinho Y, Ambler A, Ambroz L, Amelung C, Amidei D, Amor Dos Santos SP, Amoroso S, Amrouche CS, An F, Anastopoulos C, Andari N, Andeen T, Anders JK, Andrean SY, Andreazza A, Andrei V, Anelli CR, Angelidakis S, Angerami A, Anisenkov AV, Annovi A, Antel C, Anthony MT, Antipov E, Antonelli M, Antrim DJA, Anulli F, Aoki M, Aparisi Pozo JA, Aparo MA, Aperio Bella L, Aranzabal N, Araujo Ferraz V, Araujo Pereira R, Arcangeletti C, Arce ATH, Arduh FA, Arguin JF, Argyropoulos S, Arling JH, Armbruster AJ, Armstrong A, Arnaez O, Arnold H, Arrubarrena Tame ZP, Artoni G, Asada H, Asai K, Asai S, Asawatavonvanich T, Asbah N, Asimakopoulou EM, Asquith L, Assahsah J, Assamagan K, Astalos R, Atkin RJ, Atkinson M, Atlay NB, Atmani H, Atmasiddha PA, Augsten K, Austrup VA, Avolio G, Ayoub MK, Azuelos G, Babal D, Bachacou H, Bachas K, Backman F, Bagnaia P, Bahmani M, Bahrasemani H, Bailey AJ, Bailey VR, Baines JT, Bakalis C, Baker OK, Bakker PJ, Bakos E, Bakshi Gupta D, Balaji S, Balasubramanian R, Baldin EM, Balek P, Balli F, Balunas WK, Balz J, Banas E, Bandieramonte M, Bandyopadhyay A, Banerjee S, Barak L, Barbe WM, Barberio EL, Barberis D, Barbero M, Barbour G, Barillari T, Barisits MS, Barkeloo J, Barklow T, Barnea R, Barnett BM, Barnett RM, Barnovska-Blenessy Z, Baroncelli A, Barone G, Barr AJ, Barranco Navarro L, Barreiro F, Barreiro Guimarães da Costa J, Barron U, Barsov S, Bartels F, Bartoldus R, Bartolini G, Barton AE, Bartos P, Basalaev A, Basan A, Bassalat A, Basso MJ, Bates RL, Batlamous S, Batley JR, Batool B, Battaglia M, Bauce M, Bauer F, Bauer P, Bawa HS, Bayirli A, Beacham JB, Beau T, Beauchemin PH, Becherer F, Bechtle P, Beck HC, Beck HP, Becker K, Becot C, Beddall A, Beddall AJ, Bednyakov VA, Bedognetti M, Bee CP, Beermann TA, Begalli M, Begel M, Behera A, Behr JK, Beisiegel F, Belfkir M, Bell AS, Bella G, Bellagamba L, Bellerive A, Bellos P, Beloborodov K, Belotskiy K, Belyaev NL, Benchekroun D, Benekos N, Benhammou Y, Benjamin DP, Benoit M, Bensinger JR, Bentvelsen S, Beresford L, Beretta M, Berge D, Bergeaas Kuutmann E, Berger N, Bergmann B, Bergsten LJ, Beringer J, Berlendis S, Bernardi G, Bernius C, Bernlochner FU, Berry T, Berta P, Berthold A, Bertram IA, Bessidskaia Bylund O, Besson N, Bethani A, Bethke S, Betti A, Bevan AJ, Beyer J, Bhatta S, Bhattacharya DS, Bhattarai P, Bhopatkar VS, Bi R, Bianchi RM, Biebel O, Biedermann D, Bielski R, Bierwagen K, Biesuz NV, Biglietti M, Billoud TRV, Bindi M, Bingul A, Bini C, Biondi S, Birch-Sykes CJ, Birman M, Bisanz T, Biswal JP, Biswas D, Bitadze A, Bittrich C, Bjørke K, Blazek T, Bloch I, Blocker C, Blue A, Blumenschein U, Bobbink GJ, Bobrovnikov VS, Bocchetta SS, Bogavac D, Bogdanchikov AG, Bohm C, Boisvert V, Bokan P, Bold T, Bolz AE, Bomben M, Bona M, Bonilla JS, Boonekamp M, Booth CD, Borbély AG, Borecka-Bielska HM, Borgna LS, Borisov A, Borissov G, Bortoletto D, Boscherini D, Bosman M, Bossio Sola JD, Bouaouda K, Boudreau J, Bouhova-Thacker EV, Boumediene D, Boveia A, Boyd J, Boye D, Boyko IR, Bozson AJ, Bracinik J, Brahimi N, Brandt G, Brandt O, Braren F, Brau B, Brau JE, Breaden Madden WD, Brendlinger K, Brener R, Brenner L, Brenner R, Bressler S, Brickwedde B, Briglin DL, Britton D, Britzger D, Brock I, Brock R, Brooijmans G, Brooks WK, Brost E, Bruckman de Renstrom PA, Brüers B, Bruncko D, Bruni A, Bruni G, Bruschi M, Bruscino N, Bryngemark L, Buanes T, Buat Q, Buchholz P, Buckley AG, Budagov IA, Bugge MK, Bührer F, Bulekov O, Bullard BA, Burch TJ, Burdin S, Burgard CD, Burger AM, Burghgrave B, Burr JTP, Burton CD, Burzynski JC, Büscher V, Buschmann E, Bussey PJ, Butler JM, Buttar CM, Butterworth JM, Butti P, Buttinger W, Buxo Vazquez CJ, Buzatu A, Buzykaev AR, Cabras G, Cabrera Urbán S, Caforio D, Cai H, Cairo VMM, Cakir O, Calace N, Calafiura P, Calderini G, Calfayan P, Callea G, Caloba LP, Caltabiano A, Calvente Lopez S, Calvet D, Calvet S, Calvet TP, Calvetti M, Camacho Toro R, Camarda S, Camarero Munoz D, Camarri P, Camerlingo MT, Cameron D, Camincher C, Campana S, Campanelli M, Camplani A, Canale V, Canesse A, Cano Bret M, Cantero J, Cao T, Cao Y, Capeans Garrido MDM, Capua M, Cardarelli R, Cardillo F, Carducci G, Carli I, Carli T, Carlino G, Carlson BT, Carlson EM, Carminati L, Carney RMD, Caron S, Carquin E, Carrá S, Carratta G, Carter JWS, Carter TM, Casado MP, Casha AF, Castiglia EG, Castillo FL, Castillo Garcia L, Castillo Gimenez V, Castro NF, Catinaccio A, Catmore JR, Cattai A, Cavaliere V, Cavasinni V, Celebi E, Celli F, Cerny K, Cerqueira AS, Cerri A, Cerrito L, Cerutti F, Cervelli A, Cetin SA, Chadi Z, Chakraborty D, Chan J, Chan WS, Chan WY, Chapman JD, Chargeishvili B, Charlton DG, Charman TP, Chatterjee M, Chau CC, Che S, Chekanov S, Chekulaev SV, Chelkov GA, Chen B, Chen C, Chen CH, Chen H, Chen H, Chen J, Chen J, Chen J, Chen S, Chen SJ, Chen X, Chen Y, Chen YH, Cheng HC, Cheng HJ, Cheplakov A, Cheremushkina E, Cherkaoui El Moursli R, Cheu E, Cheung K, Chevalérias TJA, Chevalier L, Chiarella V, Chiarelli G, Chiodini G, Chisholm AS, Chitan A, Chiu I, Chiu YH, Chizhov MV, Choi K, Chomont AR, Chou Y, Chow YS, Christopher LD, Chu MC, Chu X, Chudoba J, Chwastowski JJ, Chytka L, Cieri D, Ciesla KM, Cindro V, Cioară IA, Ciocio A, Cirotto F, Citron ZH, Citterio M, Ciubotaru DA, Ciungu BM, Clark A, Clark PJ, Clawson SE, Clement C, Coadou Y, Cobal M, Coccaro A, Cochran J, Coelho Lopes De Sa R, Cohen H, Coimbra AEC, Cole B, Colijn AP, Collot J, Conde Muiño P, Connell SH, Connelly IA, Constantinescu S, Conventi F, Cooper-Sarkar AM, Cormier F, Cormier KJR, Corpe LD, Corradi M, Corrigan EE, Corriveau F, Costa MJ, Costanza F, Costanzo D, Cowan G, Cowley JW, Crane J, Cranmer K, Creager RA, Crépé-Renaudin S, Crescioli F, Cristinziani M, Croft V, Crosetti G, Cueto A, Cuhadar Donszelmann T, Cui H, Cukierman AR, Cunningham WR, Czekierda S, Czodrowski P, Czurylo MM, Da Cunha Sargedas De Sousa MJ, Da Fonseca Pinto JV, Da Via C, Dabrowski W, Dachs F, Dado T, Dahbi S, Dai T, Dallapiccola C, Dam M, D'amen G, D'Amico V, Damp J, Dandoy JR, Daneri MF, Danninger M, Dao V, Darbo G, Dartsi O, Dattagupta A, Daubney T, D'Auria S, David C, Davidek T, Davis DR, Dawson I, De K, De Asmundis R, De Beurs M, De Castro S, De Groot N, de Jong P, De la Torre H, De Maria A, De Pedis D, De Salvo A, De Sanctis U, De Santis M, De Santo A, De Vivie De Regie JB, Dedovich DV, Deiana AM, Del Peso J, Delabat Diaz Y, Delgove D, Deliot F, Delitzsch CM, Della Pietra M, Della Volpe D, Dell'Acqua A, Dell'Asta L, Delmastro M, Delporte C, Delsart PA, Demers S, Demichev M, Demontigny G, Denisov SP, D'Eramo L, Derendarz D, Derkaoui JE, Derue F, Dervan P, Desch K, Dette K, Deutsch C, Devesa MR, Deviveiros PO, Di Bello FA, Di Ciaccio A, Di Ciaccio L, Di Clemente WK, Di Donato C, Di Girolamo A, Di Gregorio G, Di Luca A, Di Micco B, Di Nardo R, Di Petrillo KF, Di Sipio R, Diaconu C, Dias FA, Dias Do Vale T, Diaz MA, Diaz Capriles FG, Dickinson J, Didenko M, Diehl EB, Dietrich J, Díez Cornell S, Diez Pardos C, Dimitrievska A, Ding W, Dingfelder J, Dittmeier SJ, Dittus F, Djama F, Djobava T, Djuvsland JI, Do Vale MAB, Dobre M, Dodsworth D, Doglioni C, Dolejsi J, Dolezal Z, Donadelli M, Dong B, Donini J, D'onofrio A, D'Onofrio M, Dopke J, Doria A, Dova MT, Doyle AT, Drechsler E, Dreyer E, Dreyer T, Drobac AS, Du D, du Pree TA, Duan Y, Dubinin F, Dubovsky M, Dubreuil A, Duchovni E, Duckeck G, Ducu OA, Duda D, Dudarev A, Dudder AC, Duffield EM, D'uffizi M, Duflot L, Dührssen M, Dülsen C, Dumancic M, Dumitriu AE, Dunford M, Dungs S, Duperrin A, Duran Yildiz H, Düren M, Durglishvili A, Duschinger D, Dutta B, Duvnjak D, Dyckes GI, Dyndal M, Dysch S, Dziedzic BS, Eggleston MG, Eifert T, Eigen G, Einsweiler K, Ekelof T, El Jarrari H, Ellajosyula V, Ellert M, Ellinghaus F, Elliot AA, Ellis N, Elmsheuser J, Elsing M, Emeliyanov D, Emerman A, Enari Y, Epland MB, Erdmann J, Ereditato A, Erland PA, Errenst M, Escalier M, Escobar C, Estrada Pastor O, Etzion E, Evans GE, Evans H, Evans MO, Ezhilov A, Fabbri F, Fabbri L, Fabiani V, Facini G, Fakhrutdinov RM, Falciano S, Falke PJ, Falke S, Faltova J, Fang Y, Fang Y, Fanourakis G, Fanti M, Faraj M, Farbin A, Farilla A, Farina EM, Farooque T, Farrington SM, Farthouat P, Fassi F, Fassnacht P, Fassouliotis D, Faucci Giannelli M, Fawcett WJ, Fayard L, Fedin OL, Fedorko W, Fehr A, Feickert M, Feligioni L, Fell A, Feng C, Feng M, Fenton MJ, Fenyuk AB, Ferguson SW, Ferrando J, Ferrari A, Ferrari P, Ferrari R, Ferreira de Lima DE, Ferrer A, Ferrere D, Ferretti C, Fiedler F, Filipčič A, Filthaut F, Finelli KD, Fiolhais MCN, Fiorini L, Fischer F, Fischer J, Fisher WC, Fitschen T, Fleck I, Fleischmann P, Flick T, Flierl BM, Flores L, Flores Castillo LR, Follega FM, Fomin N, Foo JH, Forcolin GT, Forland BC, Formica A, Förster FA, Forti AC, Fortin E, Foti MG, Fournier D, Fox H, Francavilla P, Francescato S, Franchini M, Franchino S, Francis D, Franco L, Franconi L, Franklin M, Frattari G, Fray AN, Freeman PM, Freund B, Freund WS, Freundlich EM, Frizzell DC, Froidevaux D, Frost JA, Fujimoto M, Fukunaga C, Fullana Torregrosa E, Fusayasu T, Fuster J, Gabrielli A, Gabrielli A, Gadatsch S, Gadow P, Gagliardi G, Gagnon LG, Gallardo GE, Gallas EJ, Gallop BJ, Gamboa Goni R, Gan KK, Ganguly S, Gao J, Gao Y, Gao YS, Garay Walls FM, García C, García Navarro JE, García Pascual JA, Garcia-Argos C, Garcia-Sciveres M, Gardner RW, Garelli N, Gargiulo S, Garner CA, Garonne V, Gasiorowski SJ, Gaspar P, Gaudiello A, Gaudio G, Gauzzi P, Gavrilenko IL, Gavrilyuk A, Gay C, Gaycken G, Gazis EN, Geanta AA, Gee CM, Gee CNP, Geisen J, Geisen M, Gemme C, Genest MH, Geng C, Gentile S, George S, Geralis T, Gerlach LO, Gessinger-Befurt P, Gessner G, Ghasemi S, Ghasemi Bostanabad M, Ghneimat M, Ghosh A, Ghosh A, Giacobbe B, Giagu S, Giangiacomi N, Giannetti P, Giannini A, Giannini G, Gibson SM, Gignac M, Gil DT, Gilbert BJ, Gillberg D, Gilles G, Gillwald NEK, Gingrich DM, Giordani MP, Giraud PF, Giugliarelli G, Giugni D, Giuli F, Gkaitatzis S, Gkialas I, Gkougkousis EL, Gkountoumis P, Gladilin LK, Glasman C, Glatzer J, Glaysher PCF, Glazov A, Gledhill GR, Gnesi I, Goblirsch-Kolb M, Godin D, Goldfarb S, Golling T, Golubkov D, Gomes A, Goncalves Gama R, Gonçalo R, Gonella G, Gonella L, Gongadze A, Gonnella F, Gonski JL, González de la Hoz S, Gonzalez Fernandez S, Gonzalez Lopez R, Gonzalez Renteria C, Gonzalez Suarez R, Gonzalez-Sevilla S, Gonzalvo Rodriguez GR, Goossens L, Gorasia NA, Gorbounov PA, Gordon HA, Gorini B, Gorini E, Gorišek A, Goshaw AT, Gostkin MI, Gottardo CA, Gouighri M, Goussiou AG, Govender N, Goy C, Grabowska-Bold I, Graham EC, Gramling J, Gramstad E, Grancagnolo S, Grandi M, Gratchev V, Gravila PM, Gravili FG, Gray C, Gray HM, Grefe C, Gregersen K, Gregor IM, Grenier P, Grevtsov K, Grieco C, Grieser NA, Grillo AA, Grimm K, Grinstein S, Grivaz JF, Groh S, Gross E, Grosse-Knetter J, Grout ZJ, Grud C, Grummer A, Grundy JC, Guan L, Guan W, Gubbels C, Guenther J, Guerguichon A, Guerrero Rojas JGR, Guescini F, Guest D, Gugel R, Guida A, Guillemin T, Guindon S, Guo J, Guo W, Guo Y, Guo Z, Gupta R, Gurbuz S, Gustavino G, Guth M, Gutierrez P, Gutschow C, Guyot C, Gwenlan C, Gwilliam CB, Haaland ES, Haas A, Haber C, Hadavand HK, Hadef A, Haleem M, Haley J, Hall JJ, Halladjian G, Hallewell GD, Hamano K, Hamdaoui H, Hamer M, Hamity GN, Han K, Han L, Han L, Han S, Han YF, Hanagaki K, Hance M, Handl DM, Hank MD, Hankache R, Hansen E, Hansen JB, Hansen JD, Hansen MC, Hansen PH, Hanson EC, Hara K, Harenberg T, Harkusha S, Harrison PF, Hartman NM, Hartmann NM, Hasegawa Y, Hasib A, Hassani S, Haug S, Hauser R, Havranek M, Hawkes CM, Hawkings RJ, Hayashida S, Hayden D, Hayes C, Hayes RL, Hays CP, Hays JM, Hayward HS, Haywood SJ, He F, He Y, Heath MP, Hedberg V, Heggelund AL, Heidegger C, Heidegger KK, Heidorn WD, Heilman J, Heim S, Heim T, Heinemann B, Heinlein JG, Heinrich JJ, Heinrich L, Hejbal J, Helary L, Held A, Hellesund S, Helling CM, Hellman S, Helsens C, Henderson RCW, Henkelmann L, Henriques Correia AM, Herde H, Hernández Jiménez Y, Herr H, Herrmann MG, Herrmann T, Herten G, Hertenberger R, Hervas L, Herwig TC, Hesketh GG, Hessey NP, Hibi H, Higashino S, Higón-Rodriguez E, Hildebrand K, Hill JC, Hill KK, Hiller KH, Hillier SJ, Hils M, Hinchliffe I, Hinterkeuser F, Hirose M, Hirose S, Hirschbuehl D, Hiti B, Hladik O, Hobbs J, Hobincu R, Hod N, Hodgkinson MC, Hoecker A, Hohn D, Hohov D, Holm T, Holmes TR, Holzbock M, Hommels LBAH, Hong TM, Honig JC, Hönle A, Hooberman BH, Hopkins WH, Horii Y, Horn P, Horyn LA, Hou S, Hoummada A, Howarth J, Hoya J, Hrabovsky M, Hrivnac J, Hrynevich A, Hryn'ova T, Hsu PJ, Hsu SC, Hu Q, Hu S, Hu YF, Huang DP, Huang X, Huang Y, Huang Y, Hubacek Z, Hubaut F, Huebner M, Huegging F, Huffman TB, Huhtinen M, Hulsken R, Hunter RFH, Huseynov N, Huston J, Huth J, Hyneman R, Hyrych S, Iacobucci G, Iakovidis G, Ibragimov I, Iconomidou-Fayard L, Iengo P, Ignazzi R, Iguchi R, Iizawa T, Ikegami Y, Ikeno M, Ilic N, Iltzsche F, Imam H, Introzzi G, Iodice M, Iordanidou K, Ippolito V, Isacson MF, Ishino M, Islam W, Issever C, Istin S, Iturbe Ponce JM, Iuppa R, Ivina A, Izen JM, Izzo V, Jacka P, Jackson P, Jacobs RM, Jaeger BP, Jain V, Jäkel G, Jakobi KB, Jakobs K, Jakoubek T, Jamieson J, Janas KW, Jansky R, Janus M, Janus PA, Jarlskog G, Jaspan AE, Javadov N, Javůrek T, Javurkova M, Jeanneau F, Jeanty L, Jejelava J, Jenni P, Jeong N, Jézéquel S, Jia J, Jia Z, Jiang H, Jiang Y, Jiang Z, Jiggins S, Jimenez Morales FA, Jimenez Pena J, Jin S, Jinaru A, Jinnouchi O, Jivan H, Johansson P, Johns KA, Johnson CA, Jones E, Jones RWL, Jones SD, Jones TJ, Jongmanns J, Jovicevic J, Ju X, Junggeburth JJ, Juste Rozas A, Kaczmarska A, Kado M, Kagan H, Kagan M, Kahn A, Kahra C, Kaji T, Kajomovitz E, Kalderon CW, Kaluza A, Kamenshchikov A, Kaneda M, Kang NJ, Kang S, Kano Y, Kanzaki J, Kaplan LS, Kar D, Karava K, Kareem MJ, Karkanias I, Karpov SN, Karpova ZM, Kartvelishvili V, Karyukhin AN, Kasimi E, Kastanas A, Kato C, Katzy J, Kawade K, Kawagoe K, Kawaguchi T, Kawamoto T, Kawamura G, Kay EF, Kaya FI, Kazakos S, Kazanin VF, Keaveney JM, Keeler R, Keller JS, Kellermann E, Kelsey D, Kempster JJ, Kendrick J, Kennedy KE, Kepka O, Kersten S, Kerševan BP, Ketabchi Haghighat S, Khalil-Zada F, Khandoga M, Khanov A, Kharlamov AG, Kharlamova T, Khoda EE, Khoo TJ, Khoriauli G, Khramov E, Khubua J, Kido S, Kiehn M, Kim E, Kim YK, Kimura N, Kirchhoff A, Kirchmeier D, Kirk J, Kiryunin AE, Kishimoto T, Kisliuk DP, Kitali V, Kitsaki C, Kivernyk O, Klapdor-Kleingrothaus T, Klassen M, Klein C, Klein MH, Klein M, Klein U, Kleinknecht K, Klimek P, Klimentov A, Klingl T, Klioutchnikova T, Klitzner FF, Kluit P, Kluth S, Kneringer E, Knoops EBFG, Knue A, Kobayashi D, Kobel M, Kocian M, Kodama T, Kodys P, Koeck DM, Koenig PT, Koffas T, Köhler NM, Kolb M, Koletsou I, Komarek T, Kondo T, Köneke K, Kong AXY, König AC, Kono T, Konstantinides V, Konstantinidis N, Konya B, Kopeliansky R, Koperny S, Korcyl K, Kordas K, Koren G, Korn A, Korolkov I, Korolkova EV, Korotkova N, Kortner O, Kortner S, Kostyukhin VV, Kotsokechagia A, Kotwal A, Koulouris A, Kourkoumeli-Charalampidi A, Kourkoumelis C, Kourlitis E, Kouskoura V, Kowalewski R, Kozanecki W, Kozhin AS, Kramarenko VA, Kramberger G, Krasnopevtsev D, Krasny MW, Krasznahorkay A, Krauss D, Kremer JA, Kretzschmar J, Krieger P, Krieter F, Krishnamurthy S, Krishnan A, Krivos M, Krizka K, Kroeninger K, Kroha H, Kroll J, Kroll J, Krowpman KS, Kruchonak U, Krüger H, Krumnack N, Kruse MC, Krzysiak JA, Kubota A, Kuchinskaia O, Kuday S, Kuechler D, Kuechler JT, Kuehn S, Kuhl T, Kukhtin V, Kulchitsky Y, Kuleshov S, Kulinich YP, Kuna M, Kupco A, Kupfer T, Kuprash O, Kurashige H, Kurchaninov LL, Kurochkin YA, Kurova A, Kurth MG, Kuwertz ES, Kuze M, Kvam AK, Kvita J, Kwan T, La Ruffa F, Lacasta C, Lacava F, Lack DPJ, Lacker H, Lacour D, Ladygin E, Lafaye R, Laforge B, Lagouri T, Lai S, Lakomiec IK, Lambert JE, Lammers S, Lampl W, Lampoudis C, Lançon E, Landgraf U, Landon MPJ, Lang VS, Lange JC, Langenberg RJ, Lankford AJ, Lanni F, Lantzsch K, Lanza A, Lapertosa A, Laporte JF, Lari T, Lasagni Manghi F, Lassnig M, Latonova V, Lau TS, Laudrain A, Laurier A, Lavorgna M, Lawlor SD, Lazzaroni M, Le B, Le Guirriec E, Lebedev A, LeBlanc M, LeCompte T, Ledroit-Guillon F, Lee ACA, Lee CA, Lee GR, Lee L, Lee SC, Lee S, Lefebvre B, Lefebvre HP, Lefebvre M, Leggett C, Lehmann K, Lehmann N, Lehmann Miotto G, Leight WA, Leisos A, Leite MAL, Leitgeb CE, Leitner R, Leney KJC, Lenz T, Leone S, Leonidopoulos C, Leopold A, Leroy C, Les R, Lester CG, Levchenko M, Levêque J, Levin D, Levinson LJ, Lewis DJ, Li B, Li B, Li CQ, Li F, Li H, Li H, Li J, Li K, Li L, Li M, Li QY, Li S, Li X, Li Y, Li Z, Li Z, Li Z, Li Z, Liang Z, Liberatore M, Liberti B, Lie K, Lim S, Lin CY, Lin K, Linck RA, Lindley RE, Lindon JH, Linss A, Lionti AL, Lipeles E, Lipniacka A, Liss TM, Lister A, Little JD, Liu B, Liu BX, Liu HB, Liu JB, Liu JKK, Liu K, Liu M, Liu MY, Liu P, Liu X, Liu Y, Liu Y, Liu YL, Liu YW, Livan M, Lleres A, Llorente Merino J, Lloyd SL, Lo CY, Lobodzinska EM, Loch P, Loffredo S, Lohse T, Lohwasser K, Lokajicek M, Long JD, Long RE, Longarini I, Longo L, Looper KA, Lopez Paz I, Lopez Solis A, Lorenz J, Lorenzo Martinez N, Lory AM, Lösel PJ, Lösle A, Lou X, Lou X, Lounis A, Love J, Love PA, Lozano Bahilo JJ, Lu M, Lu YJ, Lubatti HJ, Luci C, Lucio Alves FL, Lucotte A, Luehring F, Luise I, Luminari L, Lund-Jensen B, Luongo NA, Lutz MS, Lynn D, Lyons H, Lysak R, Lytken E, Lyu F, Lyubushkin V, Lyubushkina T, Ma H, Ma LL, Ma Y, Mac Donell DM, Maccarrone G, Macdonald CM, MacDonald JC, Machado Miguens J, Madaffari D, Madar R, Mader WF, Madugoda Ralalage Don M, Madysa N, Maeda J, Maeno T, Maerker M, Magerl V, Magini N, Magro J, Mahon DJ, Maidantchik C, Maier T, Maio A, Maj K, Majersky O, Majewski S, Makida Y, Makovec N, Malaescu B, Malecki P, Maleev VP, Malek F, Malito D, Mallik U, Malone C, Maltezos S, Malyukov S, Mamuzic J, Mancini G, Mandalia JP, Mandić I, Manhaes de Andrade Filho L, Maniatis IM, Manjarres Ramos J, Mankinen KH, Mann A, Manousos A, Mansoulie B, Manthos I, Manzoni S, Marantis A, Marceca G, Marchese L, Marchiori G, Marcisovsky M, Marcoccia L, Marcon C, Marjanovic M, Marshall Z, Martensson MUF, Marti-Garcia S, Martin CB, Martin TA, Martin VJ, Martin Dit Latour B, Martinelli L, Martinez M, Martinez Agullo P, Martinez Outschoorn VI, Martin-Haugh S, Martoiu VS, Martyniuk AC, Marzin A, Maschek SR, Masetti L, Mashimo T, Mashinistov R, Masik J, Maslennikov AL, Massa L, Massarotti P, Mastrandrea P, Mastroberardino A, Masubuchi T, Matakias D, Matic A, Matsuzawa N, Mättig P, Maurer J, Maček B, Maximov DA, Mazini R, Maznas I, Mazza SM, Mc Ginn C, Mc Gowan JP, Mc Kee SP, McCarthy TG, McCormack WP, McDonald EF, McDougall AE, Mcfayden JA, Mchedlidze G, McKay MA, McLean KD, McMahon SJ, McNamara PC, McNicol CJ, McPherson RA, Mdhluli JE, Meadows ZA, Meehan S, Megy T, Mehlhase S, Mehta A, Meirose B, Melini D, Mellado Garcia BR, Mellenthin JD, Melo M, Meloni F, Melzer A, Mendes Gouveia ED, Mendes Jacques Da Costa AM, Meng HY, Meng L, Meng XT, Menke S, Meoni E, Mergelmeyer S, Merkt SAM, Merlassino C, Mermod P, Merola L, Meroni C, Merz G, Meshkov O, Meshreki JKR, Metcalfe J, Mete AS, Meyer C, Meyer JP, Michetti M, Middleton RP, Mijović L, Mikenberg G, Mikestikova M, Mikuž M, Mildner H, Milic A, Milke CD, Miller DW, Miller LS, Milov A, Milstead DA, Minaenko AA, Minashvili IA, Mince L, Mincer AI, Mindur B, Mineev M, Minegishi Y, Mino Y, Mir LM, Mironova M, Mistry KP, Mitani T, Mitrevski J, Mitsou VA, Mittal M, Miu O, Miucci A, Miyagawa PS, Mizukami A, Mjörnmark JU, Mkrtchyan T, Mlynarikova M, Moa T, Mobius S, Mochizuki K, Moder P, Mogg P, Mohapatra S, Moles-Valls R, Mönig K, Monnier E, Montalbano A, Montejo Berlingen J, Montella M, Monticelli F, Monzani S, Morange N, Moreira De Carvalho AL, Moreno D, Moreno Llácer M, Moreno Martinez C, Morettini P, Morgenstern M, Morgenstern S, Mori D, Morii M, Morinaga M, Morisbak V, Morley AK, Mornacchi G, Morris AP, Morvaj L, Moschovakos P, Moser B, Mosidze M, Moskalets T, Moskvitina P, Moss J, Moyse EJW, Muanza S, Mueller J, Mueller RSP, Muenstermann D, Mullier GA, Mungo DP, Munoz Martinez JL, Munoz Sanchez FJ, Murin P, Murray WJ, Murrone A, Muse JM, Muškinja M, Mwewa C, Myagkov AG, Myers AA, Myers G, Myers J, Myska M, Nachman BP, Nackenhorst O, Nag AN, Nagai K, Nagano K, Nagasaka Y, Nagle JL, Nagy E, Nairz AM, Nakahama Y, Nakamura K, Nakamura T, Nanjo H, Napolitano F, Naranjo Garcia RF, Narayan R, Naryshkin I, Naseri M, Naumann T, Navarro G, Nechaeva PY, Nechansky F, Neep TJ, Negri A, Negrini M, Nellist C, Nelson C, Nelson ME, Nemecek S, Nessi M, Neubauer MS, Neuhaus F, Neumann M, Newhouse R, Newman PR, Ng CW, Ng YS, Ng YWY, Ngair B, Nguyen HDN, Nguyen Manh T, Nibigira E, Nickerson RB, Nicolaidou R, Nielsen DS, Nielsen J, Niemeyer M, Nikiforou N, Nikolaenko V, Nikolic-Audit I, Nikolopoulos K, Nilsson P, Nindhito HR, Nisati A, Nishu N, Nisius R, Nitsche I, Nitta T, Nobe T, Noel DL, Noguchi Y, Nomidis I, Nomura MA, Nordberg M, Novak J, Novak T, Novgorodova O, Novotny R, Nozka L, Ntekas K, Nurse E, Oakham FG, Ocariz J, Ochi A, Ochoa I, Ochoa-Ricoux JP, O'Connor K, Oda S, Odaka S, Oerdek S, Ogrodnik A, Oh A, Ohm CC, Oide H, Ojeda ML, Okawa H, Okazaki Y, O'Keefe MW, Okumura Y, Olariu A, Oleiro Seabra LF, Olivares Pino SA, Oliveira Damazio D, Oliver JL, Olsson MJR, Olszewski A, Olszowska J, Öncel ÖO, O'Neil DC, O'neill AP, Onofre A, Onyisi PUE, Oppen H, Oreamuno Madriz RG, Oreglia MJ, Orellana GE, Orestano D, Orlando N, Orr RS, O'Shea V, Ospanov R, Otero Y Garzon G, Otono H, Ott PS, Ottino GJ, Ouchrif M, Ouellette J, Ould-Saada F, Ouraou A, Ouyang Q, Owen M, Owen RE, Ozcan VE, Ozturk N, Pacalt J, Pacey HA, Pachal K, Pacheco Pages A, Padilla Aranda C, Pagan Griso S, Palacino G, Palazzo S, Palestini S, Palka M, Palni P, Pandini CE, Panduro Vazquez JG, Pani P, Panizzo G, Paolozzi L, Papadatos C, Papageorgiou K, Parajuli S, Paramonov A, Paraskevopoulos C, Paredes Hernandez D, Paredes Saenz SR, Parida B, Park TH, Parker AJ, Parker MA, Parodi F, Parrish EW, Parsons JA, Parzefall U, Pascual Dominguez L, Pascuzzi VR, Pasner JMP, Pasquali F, Pasqualucci E, Passaggio S, Pastore F, Pasuwan P, Pataraia S, Pater JR, Pathak A, Patton J, Pauly T, Pearkes J, Pedersen M, Pedraza Diaz L, Pedro R, Peiffer T, Peleganchuk SV, Penc O, Peng C, Peng H, Peralva BS, Perego MM, Pereira Peixoto AP, Pereira Sanchez L, Perepelitsa DV, Perez Codina E, Peri F, Perini L, Pernegger H, Perrella S, Perrevoort A, Peters K, Peters RFY, Petersen BA, Petersen TC, Petit E, Petousis V, Petridou C, Petrucci F, Pettee M, Pettersson NE, Petukhova K, Peyaud A, Pezoa R, Pezzotti L, Pham T, Phillips PW, Phipps MW, Piacquadio G, Pianori E, Picazio A, Pickles RH, Piegaia R, Pietreanu D, Pilcher JE, Pilkington AD, Pinamonti M, Pinfold JL, Pitman Donaldson C, Pitt M, Pizzimento L, Pizzini A, Pleier MA, Plesanovs V, Pleskot V, Plotnikova E, Podberezko P, Poettgen R, Poggi R, Poggioli L, Pogrebnyak I, Pohl D, Pokharel I, Polesello G, Poley A, Policicchio A, Polifka R, Polini A, Pollard CS, Polychronakos V, Ponomarenko D, Pontecorvo L, Popa S, Popeneciu GA, Portales L, Portillo Quintero DM, Pospisil S, Potamianos K, Potrap IN, Potter CJ, Potti H, Poulsen T, Poveda J, Powell TD, Pownall G, Pozo Astigarraga ME, Prades Ibanez A, Pralavorio P, Prapa MM, Prell S, Price D, Primavera M, Proffitt ML, Proklova N, Prokofiev K, Prokoshin F, Protopopescu S, Proudfoot J, Przybycien M, Pudzha D, Puri A, Puzo P, Pyatiizbyantseva D, Qian J, Qin Y, Quadt A, Queitsch-Maitland M, Racko M, Ragusa F, Rahal G, Raine JA, Rajagopalan S, Ramirez Morales A, Ran K, Rauch DM, Rauscher F, Rave S, Ravina B, Ravinovich I, Rawling JH, Raymond M, Read AL, Readioff NP, Reale M, Rebuzzi DM, Redlinger G, Reeves K, Reikher D, Reiss A, Rej A, Rembser C, Renardi A, Renda M, Rendel MB, Rennie AG, Resconi S, Resseguie ED, Rettie S, Reynolds B, Reynolds E, Rezanova OL, Reznicek P, Ricci E, Richter R, Richter S, Richter-Was E, Ridel M, Rieck P, Rifki O, Rijssenbeek M, Rimoldi A, Rimoldi M, Rinaldi L, Rinn TT, Ripellino G, Riu I, Rivadeneira P, Rivera Vergara JC, Rizatdinova F, Rizvi E, Rizzi C, Robertson SH, Robin M, Robinson D, Robles Gajardo CM, Robles Manzano M, Robson A, Rocchi A, Roda C, Rodriguez Bosca S, Rodriguez Rodriguez A, Rodríguez Vera AM, Roe S, Roggel J, Røhne O, Röhrig R, Rojas RA, Roland B, Roland CPA, Roloff J, Romaniouk A, Romano M, Rompotis N, Ronzani M, Roos L, Rosati S, Rosin G, Rosser BJ, Rossi E, Rossi E, Rossi E, Rossi LP, Rossini L, Rosten R, Rotaru M, Rottler B, Rousseau D, Rovelli G, Roy A, Roy D, Rozanov A, Rozen Y, Ruan X, Ruggeri TA, Rühr F, Ruiz-Martinez A, Rummler A, Rurikova Z, Rusakovich NA, Russell HL, Rustige L, Rutherfoord JP, Rüttinger EM, Rybar M, Rybkin G, Rye EB, Ryzhov A, Sabater Iglesias JA, Sabatini P, Sabetta L, Sacerdoti S, Sadrozinski HFW, Sadykov R, Safai Tehrani F, Safarzadeh Samani B, Safdari M, Saha P, Saha S, Sahinsoy M, Sahu A, Saimpert M, Saito M, Saito T, Sakamoto H, Salamani D, Salamanna G, Salnikov A, Salt J, Salvador Salas A, Salvatore D, Salvatore F, Salvucci A, Salzburger A, Samarati J, Sammel D, Sampsonidis D, Sampsonidou D, Sánchez J, Sanchez Pineda A, Sandaker H, Sander CO, Sanderswood IG, Sandhoff M, Sandoval C, Sankey DPC, Sannino M, Sano Y, Sansoni A, Santoni C, Santos H, Santpur SN, Santra A, Saoucha KA, Sapronov A, Saraiva JG, Sasaki O, Sato K, Sauerburger F, Sauvan E, Savard P, Sawada R, Sawyer C, Sawyer L, Sayago Galvan I, Sbarra C, Sbrizzi A, Scanlon T, Schaarschmidt J, Schacht P, Schaefer D, Schaefer L, Schäfer U, Schaffer AC, Schaile D, Schamberger RD, Schanet E, Scharf C, Scharmberg N, Schegelsky VA, Scheirich D, Schenck F, Schernau M, Schiavi C, Schildgen LK, Schillaci ZM, Schioppa EJ, Schioppa M, Schleicher KE, Schlenker S, Schmidt-Sommerfeld KR, Schmieden K, Schmitt C, Schmitt S, Schoeffel L, Schoening A, Scholer PG, Schopf E, Schott M, Schouwenberg JFP, Schovancova J, Schramm S, Schroeder F, Schulte A, Schultz-Coulon HC, Schumacher M, Schumm BA, Schune P, Schwartzman A, Schwarz TA, Schwemling P, Schwienhorst R, Sciandra A, Sciolla G, Scornajenghi M, Scuri F, Scutti F, Scyboz LM, Sebastiani CD, Sedlaczek K, Seema P, Seidel SC, Seiden A, Seidlitz BD, Seiss T, Seitz C, Seixas JM, Sekhniaidze G, Sekula SJ, Semprini-Cesari N, Sen S, Serfon C, Serin L, Serkin L, Sessa M, Severini H, Sevova S, Sforza F, Sfyrla A, Shabalina E, Shahinian JD, Shaikh NW, Shaked Renous D, Shan LY, Shapiro M, Sharma A, Sharma AS, Shatalov PB, Shaw K, Shaw SM, Shehade M, Shen Y, Sherman AD, Sherwood P, Shi L, Shimmin CO, Shimogama Y, Shimojima M, Shinner JD, Shipsey IPJ, Shirabe S, Shiyakova M, Shlomi J, Shmeleva A, Shochet MJ, Shojaii J, Shope DR, Shrestha S, Shrif EM, Shroff MJ, Shulga E, Sicho P, Sickles AM, Sideras Haddad E, Sidiropoulou O, Sidoti A, Siegert F, Sijacki D, Silva M, Silva Oliveira MV, Silverstein SB, Simion S, Simoniello R, Simpson-Allsop CJ, Simsek S, Sinervo P, Sinetckii V, Singh S, Sioli M, Siral I, Sivoklokov SY, Sjölin J, Skaf A, Skorda E, Skubic P, Slawinska M, Sliwa K, Smakhtin V, Smart BH, Smiesko J, Smirnov N, Smirnov SY, Smirnov Y, Smirnova LN, Smirnova O, Smith EA, Smith HA, Smizanska M, Smolek K, Smykiewicz A, Snesarev AA, Snoek HL, Snyder IM, Snyder S, Sobie R, Soffer A, Søgaard A, Sohns F, Solans Sanchez CA, Soldatov EY, Soldevila U, Solodkov AA, Soloshenko A, Solovyanov OV, Solovyev V, Sommer P, Son H, Sonay A, Song W, Song WY, Sopczak A, Sopio AL, Sopkova F, Sottocornola S, Soualah R, Soukharev AM, South D, Spagnolo S, Spalla M, Spangenberg M, Spanò F, Sperlich D, Spieker TM, Spigo G, Spina M, Spiteri DP, Spousta M, Stabile A, Stamas BL, Stamen R, Stamenkovic M, Stampekis A, Stanecka E, Stanislaus B, Stanitzki MM, Stankaityte M, Stapf B, Starchenko EA, Stark GH, Stark J, Staroba P, Starovoitov P, Stärz S, Staszewski R, Stavropoulos G, Stegler M, Steinberg P, Steinhebel AL, Stelzer B, Stelzer HJ, Stelzer-Chilton O, Stenzel H, Stevenson TJ, Stewart GA, Stockton MC, Stoicea G, Stolarski M, Stonjek S, Straessner A, Strandberg J, Strandberg S, Strauss M, Strebler T, Strizenec P, Ströhmer R, Strom DM, Stroynowski R, Strubig A, Stucci SA, Stugu B, Stupak J, Styles NA, Su D, Su W, Su X, Suarez NB, Sulin VV, Sullivan MJ, Sultan DMS, Sultansoy S, Sumida T, Sun S, Sun X, Suster CJE, Sutton MR, Suzuki S, Svatos M, Swiatlowski M, Swift SP, Swirski T, Sydorenko A, Sykora I, Sykora M, Sykora T, Ta D, Tackmann K, Taenzer J, Taffard A, Tafirout R, Tagiev E, Taibah RHM, Takashima R, Takeda K, Takeshita T, Takeva EP, Takubo Y, Talby M, Talyshev AA, Tam KC, Tamir NM, Tanaka J, Tanaka R, Tapia Araya S, Tapprogge S, Tarek Abouelfadl Mohamed A, Tarem S, Tariq K, Tarna G, Tartarelli GF, Tas P, Tasevsky M, Tassi E, Tateno G, Tavares Delgado A, Tayalati Y, Taylor AJ, Taylor GN, Taylor W, Teagle H, Tee AS, Teixeira De Lima R, Teixeira-Dias P, Ten Kate H, Teoh JJ, Terashi K, Terron J, Terzo S, Testa M, Teuscher RJ, Thais SJ, Themistokleous N, Theveneaux-Pelzer T, Thiele F, Thomas DW, Thomas JO, Thomas JP, Thompson EA, Thompson PD, Thomson E, Thorpe EJ, Tikhomirov VO, Tikhonov YA, Timoshenko S, Tipton P, Tisserant S, Todome K, Todorova-Nova S, Todt S, Tojo J, Tokár S, Tokushuku K, Tolley E, Tombs R, Tomiwa KG, Tomoto M, Tompkins L, Tornambe P, Torrence E, Torres H, Torró Pastor E, Toscani M, Tosciri C, Toth J, Tovey DR, Traeet A, Treado CJ, Trefzger T, Tresoldi F, Tricoli A, Trigger IM, Trincaz-Duvoid S, Trischuk DA, Trischuk W, Trocmé B, Trofymov A, Troncon C, Trovato F, Truong L, Trzebinski M, Trzupek A, Tsai F, Tseng JCL, Tsiareshka PV, Tsirigotis A, Tsiskaridze V, Tskhadadze EG, Tsopoulou M, Tsukerman II, Tsulaia V, Tsuno S, Tsybychev D, Tu Y, Tudorache A, Tudorache V, Tulbure TT, Tuna AN, Turchikhin S, Turgeman D, Turk Cakir I, Turner RJ, Turra R, Tuts PM, Tzamarias S, Tzovara E, Uchida K, Ukegawa F, Unal G, Unal M, Undrus A, Unel G, Ungaro FC, Unno Y, Uno K, Urban J, Urquijo P, Usai G, Uysal Z, Vacek V, Vachon B, Vadla KOH, Vafeiadis T, Vaidya A, Valderanis C, Valdes Santurio E, Valente M, Valentinetti S, Valero A, Valéry L, Vallance RA, Vallier A, Valls Ferrer JA, Van Daalen TR, Van Gemmeren P, Van Stroud S, Van Vulpen I, Vanadia M, Vandelli W, Vandenbroucke M, Vandewall ER, Vaniachine A, Vannicola D, Vari R, Varnes EW, Varni C, Varol T, Varouchas D, Varvell KE, Vasile ME, Vasquez GA, Vazeille F, Vazquez Furelos D, Vazquez Schroeder T, Veatch J, Vecchio V, Veen MJ, Veloce LM, Veloso F, Veneziano S, Ventura A, Verbytskyi A, Vercesi V, Verducci M, Vergel Infante CM, Vergis C, Verkerke W, Vermeulen AT, Vermeulen JC, Vernieri C, Verschuuren PJ, Vetterli MC, Viaux Maira N, Vickey T, Vickey Boeriu OE, Viehhauser GHA, Vigani L, Villa M, Villaplana Perez M, Villhauer EM, Vilucchi E, Vincter MG, Virdee GS, Vishwakarma A, Vittori C, Vivarelli I, Vogel M, Vokac P, Von Ahnen J, von Buddenbrock SE, Von Toerne E, Vorobel V, Vorobev K, Vos M, Vossebeld JH, Vozak M, Vranjes N, Vranjes Milosavljevic M, Vrba V, Vreeswijk M, Vu NK, Vuillermet R, Vukotic I, Wada S, Wagner P, Wagner W, Wagner-Kuhr J, Wahdan S, Wahlberg H, Wakasa R, Walbrecht VM, Walder J, Walker R, Walker SD, Walkowiak W, Wallangen V, Wang AM, Wang AZ, Wang C, Wang C, Wang H, Wang H, Wang J, Wang P, Wang Q, Wang RJ, Wang R, Wang R, Wang SM, Wang WT, Wang W, Wang WX, Wang Y, Wang Z, Wanotayaroj C, Warburton A, Ward CP, Ward RJ, Warrack N, Watson AT, Watson MF, Watts G, Waugh BM, Webb AF, Weber C, Weber MS, Weber SA, Weber SM, Weidberg AR, Weingarten J, Weirich M, Weiser C, Wells PS, Wenaus T, Wendland B, Wengler T, Wenig S, Wermes N, Wessels M, Weston TD, Whalen K, Wharton AM, White AS, White A, White MJ, Whiteson D, Whitmore BW, Wiedenmann W, Wiel C, Wielers M, Wieseotte N, Wiglesworth C, Wiik-Fuchs LAM, Wilkens HG, Wilkins LJ, Williams DM, Williams HH, Williams S, Willocq S, Windischhofer PJ, Wingerter-Seez I, Winkels E, Winklmeier F, Winter BT, Wittgen M, Wobisch M, Wolf A, Wölker R, Wollrath J, Wolter MW, Wolters H, Wong VWS, Wongel AF, Woods NL, Worm SD, Wosiek BK, Woźniak KW, Wraight K, Wu SL, Wu X, Wu Y, Wuerzinger J, Wyatt TR, Wynne BM, Xella S, Xia L, Xiang J, Xiao X, Xie X, Xiotidis I, Xu D, Xu H, Xu H, Xu L, Xu R, Xu T, Xu W, Xu Y, Xu Z, Xu Z, Yabsley B, Yacoob S, Yallup DP, Yamaguchi N, Yamaguchi Y, Yamamoto A, Yamatani M, Yamazaki T, Yamazaki Y, Yan J, Yan Z, Yang HJ, Yang HT, Yang S, Yang T, Yang X, Yang X, Yang Y, Yang Z, Yao WM, Yap YC, Yatsenko E, Ye H, Ye J, Ye S, Yeletskikh I, Yexley MR, Yigitbasi E, Yin P, Yorita K, Yoshihara K, Young CJS, Young C, Yu J, Yuan R, Yue X, Zaazoua M, Zabinski B, Zacharis G, Zaffaroni E, Zahreddine J, Zaitsev AM, Zakareishvili T, Zakharchuk N, Zambito S, Zanzi D, Zeißner SV, Zeitnitz C, Zemaityte G, Zeng JC, Zenin O, Ženiš T, Zerwas D, Zgubič M, Zhang B, Zhang DF, Zhang G, Zhang J, Zhang K, Zhang L, Zhang L, Zhang M, Zhang R, Zhang S, Zhang X, Zhang X, Zhang Y, Zhang Z, Zhang Z, Zhao P, Zhao Y, Zhao Z, Zhemchugov A, Zheng Z, Zhong D, Zhou B, Zhou C, Zhou H, Zhou MS, Zhou M, Zhou N, Zhou Y, Zhu CG, Zhu C, Zhu HL, Zhu H, Zhu J, Zhu Y, Zhuang X, Zhukov K, Zhulanov V, Zieminska D, Zimine NI, Zimmermann S, Zinonos Z, Ziolkowski M, Živković L, Zobernig G, Zoccoli A, Zoch K, Zorbas TG, Zou R, Zwalinski L. Medium-Induced Modification of Z-Tagged Charged Particle Yields in Pb+Pb Collisions at 5.02 TeV with the ATLAS Detector. PHYSICAL REVIEW LETTERS 2021; 126:072301. [PMID: 33666476 DOI: 10.1103/physrevlett.126.072301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/25/2020] [Revised: 11/03/2020] [Accepted: 01/08/2021] [Indexed: 06/12/2023]
Abstract
The yield of charged particles opposite to a Z boson with large transverse momentum (p_{T}) is measured in 260 pb^{-1} of pp and 1.7 nb^{-1} of Pb+Pb collision data at 5.02 TeV per nucleon pair recorded with the ATLAS detector at the Large Hadron Collider. The Z boson tag is used to select hard-scattered partons with specific kinematics, and to observe how their showers are modified as they propagate through the quark-gluon plasma created in Pb+Pb collisions. Compared with pp collisions, charged-particle yields in Pb+Pb collisions show significant modifications as a function of charged-particle p_{T} in a way that depends on event centrality and Z boson p_{T}. The data are compared with a variety of theoretical calculations and provide new information about the medium-induced energy loss of partons in a p_{T} regime difficult to measure through other channels.
Collapse
|
125
|
Cao W, Guan L, Li X, Zhang R, Li L, Zhang S, Wang C, Xie X, Jiang Z, Wan D, Chi X. Clinical Analysis of Bloodstream Infections During Agranulocytosis After Allogeneic Hematopoietic Stem Cell Transplantation. Infect Drug Resist 2021; 14:185-192. [PMID: 33500639 PMCID: PMC7826046 DOI: 10.2147/idr.s280869] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2020] [Accepted: 01/01/2021] [Indexed: 12/30/2022] Open
Abstract
Purpose To explore the epidemiological characteristics and risk factors of bloodstream infections (BSI) in patients who develop agranulocytosis fever after allogeneic hematopoietic stem cell transplantation (allo-HSCT). This study also provides a basis for the clinical treatment of BSI. Methods A retrospective analysis of 397 allo-HSCT patients in the Department of Hematology of our hospital was conducted from January 2013 to December 2017 to analyze the incidence of BSI, the distribution and types of pathogenic bacteria, and drug resistance rates. We also determined whether various parameters are risk factors to BSI, including the patient age, gender, disease type, transplantation method, stem cell source, pre-treatment with anti-thymocyte globulin (ATG), and agranulocytosis time. Results Among the 397 allo-HSCT patients, 294 had a fever during the period of agranulocytosis, and 52 cases were found to have BSI. The incidence of BSI in patients with agranulocytosis fever was 17.7% (52/294). Among the 60 pathogens detected, 43 (71.67%), 10 (16.67%), and 7 (11.67%) were Gram negative strains, Gram positive strains, and fungi, respectively. The most common bacteria were Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. The detection rate of extended-spectrum β-lactamase (ESBL) was 40.0%, and carbapenem-resistant Enterobacteriaceae (CRE) accounted for 17.9%. Single-factor and multi-factor analyses showed that pre-treatment with ATG, agranulocytosis time (≥21 days), and stem cell source were risk factors for BSI. Conclusion We found that in our hospital, BSIs in allo-HSCT patients are mainly caused by Gram-negative bacteria, and the resistance rate to carbapenem drugs is high. Pre-treatment with ATG, agranulocytosis time (≥21 days), and stem cell source are risk factors for BSI.
Collapse
|